新闻源 财富源

2019年11月21日 星期四

人福医药(600079)公告正文

人福科技:2008年半年度报告全文

公告日期:2008-07-29

武汉人福高科技产业股份有限公司2008年半年度报告全文
    
    2008年七月二十八日
    目    录
    一、重要提示………………………………………………03
    二、公司基本情况…………………………………………04
    三、股本变动及股东情况…………………………………06
    四、董事、监事和高级管理人员情况……………………08
    五、董事会报告……………………………………………09
    六、重要事项………………………………………………12
    七、财务报告………………………………………………19
    八、备查文件………………………………………………92
    九、董事、监事、高级管理人员书面确认意见…………93
    
    第一章  重 要 提 示
    
    
    本公司董事会、监事会及其全体董事、监事、高级管理人员保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
    公司半年度报告全文及其摘要经公司第六届董事会第六次会议审议通过。公司全体董事出席了本次董事会会议。半年度财务报告未经审计。
    本公司不存在大股东占用资金情况。
    公司负责人董事长王学海先生,主管会计工作负责人财务总监、副总经理吴亚君女士,会计机构负责人财务管理部部长陈礼英女士声明:保证半年度报告中财务报告的真实、完整。
     第二章  公司基本情况
    一、公司基本情况简介
    1、公司法定中文名称:武汉人福高科技产业股份有限公司
     公司法定中文名称缩写:人福科技
     公司英文名称:Wuhan Humanwell Hi-tech Industry Company Limited
     公司英文名称缩写:HWHT
    2、公司A股上市交易所:上海证券交易所
     公司A股简称:人福科技
     公司A股代码:600079
    3、公司注册地址:武汉市洪山区关山街鲁磨路369号
     公司办公地址:武汉市洪山区关山街鲁磨路369号
     邮政编码:430074
     公司国际互联网网址:http://www.humanwell.com.cn
     公司电子信箱:humanwell@vip.sina.com
    4、公司法定代表人:王学海
    5、公司总经理:李杰
    6、公司董事会秘书:刘毅
     电话:(027)87597232
     传真:(027)87596393
     E-mail:humanwell@vip.sina.com
     联系地址:武汉市洪山区关山街鲁磨路369号
     公司董事会证券事务代表:王鸣
     电话:(027)87596718-8019,87597232
     传真:(027)87596393
     E-mail:wingflag@vip.sina.com
     联系地址:武汉市洪山区关山街鲁磨路369号
    7、公司信息披露报纸名称:《中国证券报》、《上海证券报》和《证券时报》。
     登载公司半年度报告的中国证券监督管理委员会指定国际互联网网址:http://www.sse.com.cn
     公司半年度报告备置地点:公司董事会秘书处
    8、公司其他基本情况:
    企业法人营业执照注册号:4201001170264
    税务登记号码:40101300014850
    
    二、主要财务数据和指标
    1、主要会计数据和财务指标
    单位:元     币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
     本报告期末               上年度期末             本报告期末比上年度期末增 
                                                     减(%)                  
    总资产                                      2,529,954,419.00         2,417,131,461.56       4.67                     
    所有者权益(或股东权益)                    1,202,621,677.44         1,167,140,923.46       3.04                     
    每股净资产                                  3.09                     3.00                   3.04                     
    归属于上市公司股东的每股净资产              2.49                     2.40                   3.50                     
     报告期(1-6月)         上年同期               本报告期比上年同期增减( 
                                                     %)                      
    营业利润                                    64,160,070.80            43,656,870.72          46.96                    
    利润总额                                    61,164,020.97            42,860,945.35          42.70                    
    净利润                                      48,869,256.43            33,553,714.54          45.64                    
    归属于母公司的净利润                        38,558,312.62            26,460,688.01          45.72                    
    扣除非经常性损益的净利润                    40,328,357.12            27,013,242.26          49.29                    
    基本每股收益(元)                          0.10                     0.07                   42.86                    
    稀释每股收益(元)                          0.10                     0.07                   42.86                    
    净资产收益率(%)                           3.98                     2.93                   1.05个百分点             
    经营活动产生的现金流量净额                  79,349,561.77            30,677,734.85          158.66                   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、非经常性损益项目和金额
    单位:元     币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    非经常性损益项目                                                        金额                                         
    非流动资产处置损益                                                      -125,395.32                                  
    计入当期损益的政府补助,但与公司业务密切相关,按照国家统一标准定额或定                                               
    量享受的政府补助除外                                                                                                 
    除上述各项之外的其他营业外收支净额                                      -1,644,649.18                                
    合计                                                                    -1,770,044.50                                
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
     第三章   股本变动及股东情况
    
    一、股份变动情况表
    本报告期内公司股份数未发生变化。
    二、股东情况
    1、股东数量和持股情况
    单位:股
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    报告期末股东总数                                      114,329户                                                      
    前十名股东持股情况                                                                                                   
    股东名称                股东性质         持股比例(%  持股总数       报告期内增   持有有限售条件股   质押或冻结的股  
    )                          减           份数量             份数量          
    武汉当代科技产业集团股  境内非国有法人   16.4078      63,840,510     0            63,840,510         63,840,000      
    份有限公司                                                                                                           
    武汉高科国有控股集团有  境内国有法人     1.8980       7,385,011      0            0                  0               
    限公司                                                                                                               
    张玉琴                  境内自然人       0.2831       1,101,524      1,101,524    0                  未知            
    朱志刚                  境内自然人       0.1835       714,000        224,000      0                  未知            
    郭玉川                  境内自然人       0.1203       468,128        468,128      0                  未知            
    艾路明                  境内自然人       0.1202       468,051        0            0                  未知            
    武汉五洲物业发展有限公  境内非国有法人   0.1157       450,000        0            0                  未知            
    司                                                                                                                   
    胥伸兵                  境内自然人       0.1047       407,638        285,282      0                  未知            
    刘晓丽                  境内自然人       0.1038       404,089        404,089      0                  未知            
    李润宝                  境内自然人       0.0915       356,400        356,400      0                  未知            
    前十名无限售条件股东持股情况                                                                                         
    股东名称                                              持有无限售条件股份数量                         股份种类        
    武汉高科国有控股集团有限公司                          7,385,011                                      流通A股         
    张玉琴                                                1,101,524                                      流通A股         
    朱志刚                                                714,000                                        流通A股         
    郭玉川                                                468,128                                        流通A股         
    艾路明                                                468,051                                        流通A股         
    武汉五洲物业发展有限公司                              450,000                                        流通A股         
    胥伸兵                                                407,638                                        流通A股         
    刘晓丽                                                404,089                                        流通A股         
    李润宝                                                356,400                                        流通A股         
    郭媺怡                                                342,970                                        流通A股         
    上述股东关联关系或一致行动关系的说明                  公司未知前十名股东中是否存在关联关系或属于《上市公司股东持股变 
               动信息披露管理办法》规定的一致行动人。除武汉当代科技产业集团股 
               份有限公司、武汉高科国有控股集团有限公司二家法人股股东外,公司 
               未知悉其他股东所持股份的质押、冻结情况。                       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
     2、前十名有限售条件股东持有限售股份数量及限售条件
    单位:股
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    序号  有限售条件股东名   持有的有限售   有限售条件股份可上市交易情况              限售条件                           
    称                 条件股份数量   可上市交易时间        新增可上市交易股份                                     
                       数量                                                   
    1     武汉当代科技产业   63,840,510     2010-08-19            63,840,510          1)持有的非流通股股份自获得上市流  
    集团股份有限公司                                                            通权之日起,在60个月内不上市交易或 
                                           者转让;2)在第1)项承诺期满后,每 
                                           年通过上海证券交易所挂牌交易出售股 
                                           份数量占所持股份数的比例不超过15%  
                                           ;3)不以低于2005年6月17日前30个交 
                                           易日算术平均值的185%(6.00元)的  
                                           价格通过上海证券交易所挂牌交易出售 
                                           股票。                             
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    三、控股股东及实际控制人变更情况
    本报告期内公司控股股东及实际控制人没有发生变更。
     第四章  董事、监事和高级管理人员
    
    
    一、董事、监事和高级管理人员持股变动
    报告期内,公司董事、监事和高级管理人员持股情况未发生变动。
    
    二、新聘或解聘公司董事、监事、高级管理人员的情况
    1、鉴于公司第五届董事会任期届满,经2008年4月7日召开的二〇〇七年年度股东大会批准,选举王学海先生、李杰先生、艾路明先生、张小东先生、邓霞飞先生、朱建斌先生、谢获宝先生、莫洪宪女士和杨祥良先生为公司第六届董事会董事,其中谢获宝先生、莫洪宪女士和杨祥良先生为独立董事。该事项见2008年4月8日的《中国证券报》、《上海证券报》、《证券时报》上。
    2、鉴于公司第五届监事会任期届满,经2008年4月7日召开的二〇〇七年年度股东大会、职工代表大会批准,选举杜越新先生、齐谋甲先生、明华女士、杜燕云女士和李光静女士为公司第六届监事会监事,其中杜燕云女士和李光静女士为职工代表监事。该事项见2008年4月8日的《中国证券报》、《上海证券报》、《证券时报》上。
    3、经2008年4月11日召开的第六届董事会第一次会议批准,续聘李杰先生为公司总经理,续聘吴亚君女士、刘毅先生、邓霞飞先生、徐华斌先生、杜文涛先生和李名学先生为公司副总经理,续聘吴亚君女士为财务总监,续聘刘毅先生为董事会秘书。该事项见2008年4月12日的《中国证券报》、《上海证券报》、《证券时报》上。
     第五章  董事会报告
    
    
    
    一、董事会关于报告期内整体经营情况的报告
    2008年是公司实施加速发展医药产业的一年,公司依据自身产业定位,制定了战略规划,提出了筹备建设集团研发平台,进一步提高集团医药板块的整体研发实力,建立共享的研发技术和信息平台。一方面,继去年对下属药品生产企业宜昌人福药业有限责任公司、武汉人福药业有限责任公司实施营销战略后,今年对深圳新鹏生物工程技术有限公司和新疆维吾尔药业有限责任公司制定并实施适应自身快速发展的营销战略,明确各控股子公司主导产品和市场定位,同时组建与发展领域相对应的专业营销队伍,使各医药企业经营得到快速发展;另一方面,继续深化全面管理审计,以强化财务标准化管理为突破口,逐步在各经营公司开展实施,提高对经营公司财务标准化管理的监管力度,同时全面加强公司董事会建设和内部控制等基础管理工作,提高现有资金的利用效率。公司的麻醉药、计划生育药品均比去年同期有实质性增长。
    综上,报告期内公司主导产业的资产质量、市场地位和盈利能力持续增强,经营性业务的高速增长为公司下一步的发展打下了坚实的产业基础。截至2008年6月30日,公司实现主营业务收入49,261.70万元,同比增长51.22%;其中公司医药产品实现销售收入38,713.16万元,与去年同期相比增加了11,955万元,同比增长44.68%;公司整体营业利润6,416.01万元,同比增长46.96%;本年实现净利润为3,855.83万元,同比增长45.72%;扣除非经常性损益后的净利润为4,032.84万元,同比增长49.29%。
    
    二、公司主营业务及其经营状况
    1、公司主营业务的范围
    本公司主要从事医药产业产品的生产、研发和销售等。报告期内主营业务和结构未发生重大变化。
     2、主营业务分行业、产品情况表
    单位:元币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    分行业或分产   营业收入             营业成本            毛利率(%  营业收入比上年同  营业成本比上年同  毛利率比上年  
    品                                                      )         期增减(%)       期增减(%)       同期增减(%) 
    分行业                                                                                                               
    医药           387,131,578.66       176,376,950.43      54.44      44.68             38.71             增加1.96个百  
                                                                分点          
    房地产         37,764,017.12        18,434,569.85       51.18      46.69             12.57             增加14.79个百 
                                                                分点          
    其他           67,721,354.45        57,789,163.82       14.67      108.74            109.18            减少0.18个百  
                                                                分点          
    分产品                                                                                                               
    药品           334,370,775.58       139,763,354.14      58.20      46.24             44.56             增加0.50个百  
                                                                分点          
    安全套         52,760,803.08        36,613,596.29       30.52      35.61             20.23             增加8.87个百  
                                                                分点          
    商品房         30,242,633.00        13,135,734.60       56.57      52.72             -0.73             增加23.39个百 
                                                                分点          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    其中:报告期内上市公司向控股股东及其子公司销售产品或提供劳务的关联交易金额为0万元。
    3、主营业务分地区情况表
    单位:元 币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    地区                    营业收入                                        营业收入比上年增减(%)                      
    东北                    11,796,314.57                                   42.88                                        
    华北                    174,993,150.97                                  68.59                                        
    华中                    157,032,982.60                                  30.26                                        
    华东                    38,406,202.47                                   23.90                                        
    西北                    18,519,417.97                                   29.00                                        
    西南                    33,571,180.03                                   53.29                                        
    华南                    35,591,807.67                                   79.14                                        
    出口                    22,705,893.95                                   276.31                                       
    其中:关联交易                                                                                                       
    合计                    492,616,950.23                                  51.22                                        
    内部抵消                                                                                                             
    合计                    492,616,950.23                                  51.22                                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    4、主要控股公司经营情况:
    
    宜昌人福药业有限责任公司注册资本18,045.00万元,宜昌人福是国家麻醉药品定点生产企业、国家高新技术企业、火炬计划项目承担单位。其主营业务为麻醉药品、原料药及成药的开发、生产、销售;主要产品为瑞芬太尼、枸橼酸芬太尼注射液、杜冷丁注射液等。宜昌人福实施的麻醉系列新药产业化项目已被国家发改委列入国家高新技术产业化示范工程。公司生产经营204个品种品规的制剂及原料药,拥有国内独家生产的枸橼酸芬太尼原料及制剂;拥有国家二类新药盐酸瑞芬太尼原料及冻干粉针剂;拥有国家三类新药枸橼酸舒芬太尼原料及制剂。除麻精类药品外,公司还生产奥珞彤、枢络、福必安、泰瑞特、普复舒、倍泰等名牌产品,在业内具有较高的知名度和良好的信誉。截至2008年6月30日,该公司总资产448,055,055.09元,净资产242,282,766.06元,主营业务收入208,874,636.88元,净利润30,088,872.64元。
    湖北葛店人福药业有限责任公司注册资本6,648.70万元。葛店人福是专业从事计划生育药物和甾体原料药及制剂的研发、生产和销售的新型现代化制药企业。其主要产品为单方、复方米非司酮片,非那雄胺及胶囊,醋酸环丙孕酮,奥卡西平等。几年来,公司相继建立了标准化的生产管理系统和质量保证体系,全部车间均通过了国家GMP认证及ISO14001(环境管理体系)认证,公司的部分原料药已通过COS(欧洲药典适应性证书)认证。公司实施的复方米非司酮产业化项目已被国家发改委列入国家高新技术产业化示范工程。截至2008年6月30日,该公司总资产130,074,049.56元,净资产82,328,502.10元,主营业务收入40,816,590.35元,净利润7,234,988.62元。
    5、报告期内,公司主营业务及其结构与上年度比较未发生重大变化。
    6、报告期内,主营业务盈利能力与上年度相比未发生重大变化。
    7、报告期内,公司利润构成与上年度相比未发生重大变化。
    三、公司报告期内的投资情况
    1、募集资金使用情况
    报告期内,公司无募集资金或前期募集资金使用延续至本期的情况。
    2、报告期内非募集资金的重大投资情况
    报告期内,公司无非募集资金重大投资的情况。
     第六章  重要事项
    
    一、公司治理的情况
    公司按照《公司法》、《证券法》和中国证监会及上海证券交易所等颁布的相关法律、法规及规章,不断完善公司法人治理结构,加强内部控制,依法规范运作,强化信息披露。
    1、公司已经从2007 年10月开始启动内部控制制度的整体规划工作,已制订并审议通过了《内部控制管理制度》,在对内部控制框架及总体工作计划初步确认后开始梳理相关内部控制制度,对现有的内部控制制度进行补充、修订和完善,将逐步完成内控手册的初稿编制工作,经公司董事会或股东大会审核通过后在公司及控股子公司中全面实施。
    2008年3月16日,公司2007年年报中披露了董事会关于内部控制制度的自我评估报告和经大信会计师事务所有限公司出具的核实评价意见,对公司的内部控制做出详细披露。核查认为:公司的内部控制制度合理有效。
    2008年4月11日,公司召开第六届董事会第一次会议,为进一步加强内部控制管理,决定设立公司“内部控制监察委员会”,并选举董事长王学海先生为主任委员。公司的内部控制建设、检查、监督的工作由该委员会全面负责,该委员会直接向董事会报告。
    2、2008年7月16日,公司召开第六届董事会第五次会议。按照中国证监会和湖北证监局的要求,以董事长王学海先生为自查小组组长,由公司董事会秘书处、财务管理部和审计部等主要职能部门人员组成专门力量,对证监会公司治理整改报告中所列事项展开了内部自查自纠。公司对2007年开展公司治理专项活动以来的情况进行了回顾和反思,对活动开展以来证监会和湖北证监局指出的整改问题的整改效果进行了评估。
    会议一致认为:公司高度重视公司治理专项活动,深入学习,认真组织,整改及时,效果良好;公司按要求分阶段及时发布报告,对上级检查和公司自查中发现的问题进行整改,在限期内完成了整改,效果良好。会议审议并一致通过了《关于公司治理专项活动整改情况的总结报告》及《防范控股股东及关联方资金占用管理办法》。
    3、根据中国证监会《关于防止大股东占用上市公司资金问题复发的通知》(上市部函[2008]101号)及《关于强化持续监管,防止资金占用问题反弹的通知》(上市部函[2008]118号)的有关要求,湖北证监局下发了《关于开展大股东及其关联方非经营性占用上市公司资金情况自查自纠工作的通知》,公司按照湖北证监局的整体部署,以董事长王学海为公司自查小组组长,对大股东占用上市公司资金问题展开专门自查,现做如下说明:
    (1)关于公司的独立性
    公司与控股股东之间从业务、人员、产权、公司机构和财务等五方面做到了“五独立”,是一个能够独立自主经营的合法主体。
    (2)关于大股东及其关联方占用上市公司资金问题
    公司一直以来对与关联公司,尤其是大股东的资金往来都严格把关,从严审核。尤其是2007年开展公司治理专项活动以来,公司管理层更是把这一问题作为公司治理中的重点高度关注,在公司2007年年报中详细的披露了经合格会计师事务所审计后的与关联方资金往来情况。审计表明:截止2007年12月31日,公司没有违反证监会(2003年56号)《关于规范上市公司与关联方资金往来及上市公司对外担保若干问题的通知》中的规定事件的发生,公司不存在大股东违规占用上市公司资金问题。
    本次从收到证监会的通知和参加湖北证监局“加强上市公司规范运作专题会议”后,经财务及审计部门查明,截止2008年6月30日,公司同样不存在大股东违规占用上市公司资金问题。
    (3)规范关联交易的情况
    公司于2007年7月26日召开的第五届董事会第二十七次会议、2007年8月15日召开的二〇〇七年第三次临时股东大会审议并通过了《武汉人福高科技产业股份有限公司关联交易公允决策制度》,严格执行中国证券监督管理委员会有关规范关联交易行为和关联关系的规定,保证公司与关联方之间签订的关联交易合同符合公平、公正、公开的原则,确保公司的关联交易行为不损害公司和全体股东利益。
    二、报告期实施的利润分配方案执行情况
    公司二〇〇七年年度利润分配方案已获2008年4月7日召开的二〇〇七年年度股东大会审议通过。报告期内公司实施了上述方案:以公司2007年末总股本389,085,686股为基数,每10股派发现金0.15元(含税),共计派发现金红利5,836,285.29元。
    2008年6月3日,公司发布临时公告,正式实施该方案。具体情况分别刊登在2008年4月8日、2008年6月3日的《中国证券报》、《上海证券报》、《证券时报》上。
    
    三、公司中期不进行利润分配、资本公积金转增股本。
    
    四、报告期内,公司不存在发生及以前期间发生但持续到报告期的重大诉讼、仲裁事项。
    
    五、资产交易事项
    (一)报告期内,公司无收购资产情况。
    (二)报告期内,公司无出售资产情况。
    (三)报告期内,公司无资产转换情况。
    (四)报告期内,公司无吸收合并情况。
    
    六、报告期内公司重大关联交易事项。
    (一)与日常经营相关的关联交易
    报告期内,公司未发生与日常经营相关的重大关联交易。
    (二)资产、股权转让的重大关联交易
    报告期内,公司未发生有关资产、股权转让的重大关联交易。
    (三)报告期内,上市公司未发生与控股股东及其子公司的非经营性关联债权债务往来。
    
    七、报告期内,公司无托管事项。
    
    八、报告期内,公司无承包事项。
    
    九、报告期内,公司无租赁事项。
    
    十、担保情况  
    单位:万元
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    公司对子公司的担保情况                                                                                               
    报告期内对子公司担保发生额合计                                        8,500.00                                       
    报告期末对子公司担保余额合计                                          24,273.00                                      
    公司担保总额情况(包括对子公司的担保)                                                                               
    担保总额                                                              24,273.00                                      
    担保总额占公司净资产的比例                                            20.797%                                        
    其中:                                                                                                               
    为股东、实际控制人及其关联方提供担保的金额                            0                                              
    直接或间接为资产负债率超过70%的被担保对象提供的债务担保金额          0                                              
    担保总额超过净资产50%部分的金额                                      0                                              
    上述三项担保金额合计                                                  0                                              
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    十一、报告期内,公司无委托理财事项。
    
    十二、报告期内,公司无其他重大合同。
    
    十三、承诺事项履行情况
    (一)公司第一大股东武汉当代科技产业集团股份有限公司(以下简称“当代科技”)承诺并正在积极履行股权分置改革时的承诺:
    1、持有的非流通股股份自获得上市流通权之日起在60个月内不上市交易或转让;
    2、在第1项承诺期满后,每年通过上海证券交易所挂牌交易出售股份数量占所持股份数的比例不超过15%;
    3、不以低于2005年6月17日前30个交易日算术平均值的185%(6.00元)的价格通过上海证券交易所挂牌交易出售股票。
    (二)根据中国证券监督管理委员会《上市公司证券发行管理办法》的要求,当代科技于2008年4月11日向本公司出具《武汉当代科技产业集团股份有限公司关于参与人福科技二〇〇八年配股认购的承诺函》。具体承诺事宜如下:
    1、当代科技将严格按照法律、法规的规定行使股东权利,履行股东义务;
    2、当代科技在上市公司配股方案最终确定后,将全部认购其可认购的配股份额;
    3、当代科技将积极配合上市公司履行信息披露义务,切实维护上市公司及其中小股东的利益。
    
    十四、报告期内,公司未改聘会计师事务所。
    
    十五、报告期内,公司及其董事、监事、高级管理人员、公司股东、实际控制人均未受中国证监会的稽查、行政处罚、通报批评及证券交易所的公开谴责。
    
    十六、其它重大事项及其影响和解决方案的分析说明
    (一)证券投资情况
    报告期内,公司无证券投资行为。
    (二)公司持有非上市金融企业股权的情况
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    持有对象名称                             最初投资成本(元  持股数量(股)     占该公司股权比例(  期末账面价值(元) 
    )                                   %)                                    
    汉口银行股份有限公司(原“武汉市商业银   5,150,000.00      6,150,000.00       0.274               5,150,000.00       
    行”)                                                                                                               
    宜昌市商业银行                           10,000,000.00     10,000,000.00      1.82                10,000,000.00      
    天风证券经纪有限责任公司                 44,575,820.00     26,000,000.00      14.37               36,250,336.92      
    小计                                     59,725,820.00     ——               ——                51,400,336.92      
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三)公司持股5%以上股东2008年追加股份限售承诺的情况
    报告期内,公司持股5%以上股东2008年无追加股份限售承诺的情况。
    十七、公告索引
    
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    公告编号             事项                 刊载的报刊                 刊载日期      刊载的互联网网站及检索路径        
    临2008-001号         董事会公告           《中》、《上》、《证》     2008-1-19     上海证券交易所(http://www.sse.co 
                                            m.cn)                            
    临2008-002号         第五届董事会第三十   《中》、《上》、《证》     2008-1-26     上海证券交易所(http://www.sse.co 
    一次会议决议公告                                              m.cn)                            
    临2008-003号         提示性公告           《中》、《上》、《证》     2008-1-26     上海证券交易所(http://www.sse.co 
                                            m.cn)                            
    临2008-004号         第五届董事会第三十   《中》、《上》、《证》     2008-3-17     上海证券交易所(http://www.sse.co 
    二次会议决议公告暨                                            m.cn)                            
    公司二〇〇七年年度                                                                              
    股东大会通知公告                                                                                
    临2008-005号         第五届监事会第九次   《中》、《上》、《证》     2008-3-17     上海证券交易所(http://www.sse.co 
    会议决议公告                                                  m.cn)                            
    临2008-006号         董事会公告           《中》、《上》、《证》     2008-3-19     上海证券交易所(http://www.sse.co 
                                            m.cn)                            
    临2008-007号         关于二〇〇七年年度   《中》、《上》、《证》     2008-4-2      上海证券交易所(http://www.sse.co 
    股东大会的提示性通                                            m.cn)                            
    知公告                                                                                          
    临2008-008号         二〇〇七年年度股东   《中》、《上》、《证》     2008-4-8      上海证券交易所(http://www.sse.co 
    大会决议公告                                                  m.cn)                            
    临2008-009号         职工代表大会决议公   《中》、《上》、《证》     2008-4-8      上海证券交易所(http://www.sse.co 
    告                                                            m.cn)                            
    临2008-010号         关于更换股权分置改   《中》、《上》、《证》     2008-4-11     上海证券交易所(http://www.sse.co 
    革保荐代表人的公告                                            m.cn)                            
    临2008-011号         第六届董事会第一次   《中》、《上》、《证》     2008-4-12     上海证券交易所(http://www.sse.co 
    会议决议公告暨公司                                            m.cn)                            
    二〇〇八年第一次临                                                                              
    时股东大会通知公告                                                                              
    临2008-012号         第六届监事会第一次   《中》、《上》、《证》     2008-4-12     上海证券交易所(http://www.sse.co 
    会议决议公告                                                  m.cn)                            
    临2008-013号         公司第一大股东参与   《中》、《上》、《证》     2008-4-12     上海证券交易所(http://www.sse.co 
    上市公司二〇〇八年                                            m.cn)                            
    配股的承诺事项公告                                                                              
    临2008-014号         董事会关于二〇〇八   《中》、《上》、《证》     2008-4-17     上海证券交易所(http://www.sse.co 
    年第一次临时股东大                                            m.cn)                            
    会的第一次提示性通                                                                              
    知公告                                                                                          
    临2008-015号         董事会关于二〇〇八   《中》、《上》、《证》     2008-4-23     上海证券交易所(http://www.sse.co 
    年第一次临时股东大                                            m.cn)                            
    会的第二次提示性通                                                                              
    知公告                                                                                          
    临2008-016号         二〇〇八年第一次临   《中》、《上》、《证》     2008-4-29     上海证券交易所(http://www.sse.co 
    时股东大会决议公告                                            m.cn)                            
    临2008-017号         第六届董事会第三次   《中》、《上》、《证》     2008-5-9      上海证券交易所(http://www.sse.co 
    会议决议公告                                                  m.cn)                            
    临2008-018号         第六届董事会第四次   《中》、《上》、《证》     2008-5-27     上海证券交易所(http://www.sse.co 
    会议决议公告                                                  m.cn)                            
    临2008-019号         二〇〇七年年度分红   《中》、《上》、《证》     2008-6-3      上海证券交易所(http://www.sse.co 
    派息实施公告                                                  m.cn)                            
    临2008-020号         董事会公告           《中》、《上》、《证》     2008-6-20     上海证券交易所(http://www.sse.co 
                                            m.cn)                            
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    注:《中》:指《中国证券报》  《上》:指《上海证券报》  《证》:指《证券时报》
    十八、期后事项
    1、公司于2008年7月16日召开第六届董事会第五次会议,审议通过了公司《防范控制股东及关联方资金占用管理办法》,建立健全了防止控股股东及关联方占用公司资金的长效机制,杜绝控股股东及关联方资金占用行为的发生。具体情况分别刊登在2008年7月18日的《中国证券报》、《上海证券报》、《证券时报》上。
    2、公司于2008年7月16日召开第六届董事会第五次会议,审计通过了公司为控股子公司天津中生乳胶有限公司(以下简称“天津中生”,我公司持有其90%的股权)在中国工商银行股份有限公司天津河北支行申请办理的借款人民币壹仟伍佰万元(¥15,000,000.00)、期限壹年的贷款提供连带责任担保的议案。公司董事会授权相关部门负责办理相关手续。具体情况分别刊登在2008年7月18日的《中国证券报》、《上海证券报》、《证券时报》上。
     第七章    财务报告
    
    一、报告期比较格式的比较式利润表、资产负债表、现金流量表、所有者权益变动表(未经审计)。
    二、会计报表附注见附件。
     合并资产负债表
    编制单位:武汉人福高科技产业股份有限公司    报告截止日:2008年06月30日     单位:元 币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                          附注              期末余额                  年初余额                   
    流动资产:                                                                                                           
    货币资金                                                        173,609,618.36            138,417,179.55             
    结算备付金                                                                                                           
    拆出资金                                                                                                             
    交易性金融资产                                                                                                       
    应收票据                                                        6,844,430.00              9,773,427.74               
    应收账款                                                        232,752,688.71            179,265,629.93             
    预付款项                                                        217,629,363.06            282,570,021.32             
    应收保费                                                                                                             
    应收分保账款                                                                                                         
    应收分保合同准备金                                                                                                   
    应收利息                                                                                                             
    应收股利                                                        2,000,000.00              2,000,000.00               
    其他应收款                                                      208,160,991.40            298,710,799.50             
    买入返售金融资产                                                                                                     
    存货                                                            467,125,406.72            438,870,725.19             
    一年内到期的非流动资产                                                                                               
    其他流动资产                                                                                                         
    流动资产合计                                                    1,308,122,498.25          1,349,607,783.23           
    非流动资产:                                                                                                         
    发放贷款及垫款                                                                                                       
    可供出售金融资产                                                                                                     
    持有至到期投资                                                                                                       
    长期应收款                                                                                                           
    长期股权投资                                                    596,690,310.94            437,412,813.38             
    投资性房地产                                                    160,452,856.87            163,038,722.17             
    固定资产                                                        378,528,047.90            381,196,899.15             
    在建工程                                                        17,610,611.34             16,374,120.85              
    工程物资                                                        80,464.29                 80,464.29                  
    固定资产清理                                                                                                         
    生产性生物资产                                                                                                       
    油气资产                                                                                                             
    无形资产                                                        58,541,453.66             60,162,628.97              
    开发支出                                                                                                             
    商誉                                                            6,681,649.45              6,681,649.45               
    长期待摊费用                                                    730,719.20                619,513.33                 
    递延所得税资产                                                  2,515,807.10              1,956,866.74               
    其他非流动资产                                                                                                       
    非流动资产合计                                                  1,221,831,920.75          1,067,523,678.33           
    资产总计                                                        2,529,954,419.00          2,417,131,461.56           
    流动负债:                                                                                                           
    短期借款                                                        695,790,000.00            691,290,000.00             
    向中央银行借款                                                                                                       
    吸收存款及同业存放                                                                                                   
    拆入资金                                                                                                             
    交易性金融负债                                                                                                       
    应付票据                                                        18,842,857.80             28,783,585.28              
    应付账款                                                        125,597,992.99            101,596,047.38             
    预收款项                                                        161,959,996.09            129,291,465.42             
    卖出回购金融资产款                                                                                                   
    应付手续费及佣金                                                                                                     
    应付职工薪酬                                                    1,461,183.89              1,575,079.73               
    应交税费                                                        46,560,563.33             42,152,441.60              
    应付利息                                                                                                             
    应付股利                                                        10,220,421.92             8,755,580.60               
    其他应付款                                                      202,894,671.79            180,700,284.02             
    应付分保账款                                                                                                         
    保险合同准备金                                                                                                       
    代理买卖证券款                                                                                                       
    代理承销证券款                                                                                                       
    一年内到期的非流动负债                                          26,000,000.00             25,400,000.00              
    其他流动负债                                                                                                         
    流动负债合计                                                    1,289,327,687.81          1,209,844,583.03           
    非流动负债:                                                                                                         
    长期借款                                                        8,000,000.00              13,000,000.00              
    应付债券                                                                                                             
    长期应付款                                                      12,272,728.00             12,272,728.00              
    专项应付款                                                      17,675,948.33             14,823,333.33              
    预计负债                                                                                                             
    递延所得税负债                                                  56,377.42                 49,893.74                  
    其他非流动负债                                                                                                       
    非流动负债合计                                                  38,005,053.75             40,145,955.07              
    负债合计                                                        1,327,332,741.56          1,249,990,538.10           
    所有者权益(或股东权益):                                                                                           
    实收资本(或股本)                                              389,085,686.00            389,085,686.00             
    资本公积                                                        255,483,746.25            255,483,746.25             
    减:库存股                                                                                                           
    盈余公积                                                        63,143,020.64             63,143,020.64              
    一般风险准备                                                                                                         
    未分配利润                                                      260,586,567.65            227,864,557.48             
    外币报表折算差额                                                                                                     
    归属于母公司所有者权益合计                                      968,299,020.54            935,577,010.37             
    少数股东权益                                                    234,322,656.90            231,563,913.09             
    所有者权益合计                                                  1,202,621,677.44          1,167,140,923.46           
    负债和所有者总计                                                2,529,954,419.00          2,417,131,461.56           
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海         主管会计工作负责人:吴亚君      会计机构负责人:陈礼英
     母公司资产负债表
    编制单位:武汉人福高科技产业股份有限公司    报告截止日:2008年06月30日     单位:元 币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                         附注              期末余额                   年初余额                   
    流动资产:                                                                                                           
    货币资金                                                       47,080,647.85              37,966,880.06              
    交易性金融资产                                                                                                       
    应收票据                                                                                                             
    应收账款                                                                                  55,569.39                  
    预付款项                                                       138,390,362.87             197,234,400.37             
    应收利息                                                                                                             
    应收股利                                                       3,304,000.00               2,000,000.00               
    其他应收款                                                     213,245,285.19             257,031,736.54             
    存货                                                           174,231,727.86             132,469,590.33             
    一年内到期的非流动资产                                                                                               
    其他流动资产                                                                                                         
    流动资产合计                                                   576,252,023.77             626,758,176.69             
    非流动资产:                                                                                                         
    可供出售金融资产                                                                                                     
    持有至到期投资                                                                                                       
    长期应收款                                                                                                           
    长期股权投资                                                   1,245,007,316.10           1,086,438,754.18           
    投资性房地产                                                                                                         
    固定资产                                                       22,049,787.78              23,470,434.54              
    在建工程                                                                                                             
    工程物资                                                                                                             
    固定资产清理                                                                                                         
    生产性生物资产                                                                                                       
    油气资产                                                                                                             
    无形资产                                                       411,580.00                 427,410.00                 
    开发支出                                                                                                             
    商誉                                                                                                                 
    长期待摊费用                                                                                                         
    递延所得税资产                                                                                                       
    其他非流动资产                                                                                                       
    非流动资产合计                                                 1,267,468,683.88           1,110,336,598.72           
    资产总计                                                       1,843,720,707.65           1,737,094,775.41           
    流动负债:                                                                                                           
    短期借款                                                       448,650,000.00             440,650,000.00             
    交易性金融负债                                                                                                       
    应付票据                                                                                  14,910,000.00              
    应付账款                                                       44,920.97                  44,920.97                  
    预收款项                                                       96,829,712.00              72,886,112.00              
    应付职工薪酬                                                   25,592.75                  18,691.69                  
    应交税费                                                       363,987.16                 2,161,744.23               
    应付利息                                                                                                             
    应付股利                                                       341,740.32                 3,064,144.00               
    其他应付款                                                     446,569,812.95             371,651,583.29             
    一年内到期的非流动负债                                         11,000,000.00              11,000,000.00              
    其他流动负债                                                                                                         
    流动负债合计                                                   1,003,825,766.15           916,387,196.18             
    非流动负债:                                                                                                         
    长期借款                                                                                                             
    应付债券                                                                                                             
    长期应付款                                                                                                           
    专项应付款                                                                                                           
    预计负债                                                                                                             
    递延所得税负债                                                                                                       
    其他非流动负债                                                                                                       
    非流动负债合计                                                                                                       
    负债合计                                                       1,003,825,766.15           916,387,196.18             
    所有者权益(或股东权益):                                                                                           
    实收资本(或股本)                                             389,085,686.00             389,085,686.00             
    资本公积                                                       249,389,742.67             249,389,742.67             
    减:库存股                                                                                                           
    盈余公积                                                       63,143,020.64              63,143,020.64              
    未分配利润                                                     138,276,492.19             119,089,129.92             
    所有者权益(或股东权益)合计                                   839,894,941.50             820,707,579.23             
    负债和所有者(或股东权益)合计                                 1,843,720,707.65           1,737,094,775.41           
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海        主管会计工作负责人:吴亚君       会计机构负责人:陈礼英
     合并利润表
    编制单位:武汉人福高科技产业股份有限公司                             单位:元      币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                               附注            本期金额                  上期金额                
    一、营业总收入                                                     492,616,950.23            325,763,158.92          
    其中:营业收入                                                     492,616,950.23            325,763,158.92          
    利息收入                                                                                                             
    已赚保费                                                                                                             
    手续费及佣金收入                                                                                                     
    二、营业总成本                                                     452,057,855.13            312,694,582.99          
    其中:营业成本                                                     252,600,684.11            171,162,355.39          
    利息支出                                                                                                             
    手续费及佣金支出                                                                                                     
    退保金                                                                                                               
    赔付支出净额                                                                                                         
    提取保险合同准备金净额                                                                                               
    保单红利支出                                                                                                         
    分保费用                                                                                                             
    营业税金及附加                                                     5,295,361.89              3,458,482.31            
    销售费用                                                           101,989,016.68            65,657,505.41           
    管理费用                                                           62,489,582.26             47,195,941.94           
    财务费用                                                           27,392,348.08             22,456,139.01           
    资产减值损失                                                       2,290,862.11              2,764,158.93            
    加:公允价值变动收益(损失以“-”号填列)                                                                           
    投资收益(损失以“-”号填列)                                     23,600,975.70             30,588,294.79           
    其中:对联营企业和合营企业的投资收益                               2,664,283.68              7,934,485.01            
    汇兑收益(损失以“-”号填列)                                                                                        
    三、营业利润(亏损以“-”号填列)                                 64,160,070.80             43,656,870.72           
    加:营业外收入                                                     62,931.03                 198,730.48              
    减:营业外支出                                                     3,058,980.86              994,655.85              
    其中:非流动资产处置净损失                                         182,926.05                442,845.95              
    四、利润总额(亏损总额以“-”号填列)                             61,164,020.97             42,860,945.35           
    减:所得税费用                                                     12,294,764.54             9,307,230.81            
    五、净利润(净亏损以“-”号填列)                                 48,869,256.43             33,553,714.54           
    归属于母公司所有者的净利润                                         38,558,312.62             26,460,688.01           
    少数股东损益                                                       10,310,943.81             7,093,026.53            
    六、每股收益:                                                                                                       
    (一)基本每股收益(元/股)                                        0.10                      0.07                    
    (二)稀释每股收益(元/股)                                        0.10                      0.07                    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海       主管会计工作负责人:吴亚君       会计机构负责人:陈礼英
     母公司利润表
    编制单位:武汉人福高科技产业股份有限公司                              单位:元     币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                               附注            本期金额                  上期金额                
    一、营业收入                                                       30,242,633.00                                     
    减:营业成本                                                       13,135,734.60                                     
    营业税金及附加                                                     1,905,285.88                                      
    销售费用                                                           165,000.44                                        
    管理费用                                                           10,087,327.37             7,230,397.78            
    财务费用                                                           18,976,922.89             14,708,856.94           
    资产减值损失                                                       -71,949.20                1,292,757.28            
    加:公允价值变动收益(损失以“-”号填列)                                                                           
    投资收益(损失以“-”号填列)                                     39,353,840.06             23,758,089.26           
    其中:对联营企业和合营企业的投资收益                               1,955,348.04              1,259,054.49            
    二、营业利润(亏损以“-”号填列)                                 25,398,151.08             526,077.26              
    加:营业外收入                                                     5,732.49                                          
    减:营业外支出                                                     380,218.85                354,284.16              
    其中:非流动资产处置净损失                                         80,218.85                                         
    三、利润总额(亏损总额以“-”号填列)                             25,023,664.72             171,793.10              
    减:所得税费用                                                                                                       
    四、净利润(净亏损以“-”号填列)                                 25,023,664.72             171,793.10              
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海       主管会计工作负责人:吴亚君        会计机构负责人:陈礼英
     合并现金流量表
    编制单位:武汉人福高科技产业股份有限公司                             单位:元      币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                               附注        本期金额           上期金额           
    一、经营活动产生的现金流量:                                                                                         
    销售商品、提供劳务收到的现金                                                   533,396,778.03     372,098,654.01     
    客户存款和同业存放款项净增加额                                                                                       
    向中央银行借款净增加额                                                                                               
    向其他金融机构拆入资金净增加额                                                                                       
    收到原保险合同保费取得的现金                                                                                         
    收到再保险业务现金净额                                                                                               
    保户储金及投资款净增加额                                                                                             
    处置交易性金融资产净增加额                                                                                           
    收取利息、手续费及佣金的现金                                                                                         
    拆入资金净增加额                                                                                                     
    回购业务资金净增加额                                                                                                 
    收到的税费返还                                                                 162,942.32         96,755.35          
    收到其他与经营活动有关的现金                                                   146,519,323.21     96,016,901.52      
    经营活动现金流入小计                                                           680,079,043.56     468,212,310.88     
    购买商品、接受劳务支付的现金                                                   277,336,136.59     214,778,681.88     
    客户贷款及垫款净增加额                                                                                               
    存放中央银行和同业款项净增加额                                                                                       
    支付原保险合同赔付款项的现金                                                                                         
    支付利息、手续费及佣金的现金                                                                                         
    支付保单红利的现金                                                                                                   
    支付给职工以及为职工支付的现金                                                 54,860,357.22      41,121,334.79      
    支付的各项税费                                                                 47,027,911.52      57,331,065.29      
    支付其他与经营活动有关的现金                                                   221,505,076.46     124,303,494.07     
    经营活动现金流出小计                                                           600,729,481.79     437,534,576.03     
    经营活动产生的现金流量净额                                                     79,349,561.77      30,677,734.85      
    二、投资活动产生的现金流量:                                                                                         
    收回投资收到的现金                                                             1,900,000.00       600,000.00         
    取得投资收益收到的现金                                                                            1,000,000.00       
    处置固定资产、无形资产和其他长期资产收回的现金净额                             257,465.00         1,819,514.18       
    处置子公司及其他营业单位收到的现金净额                                                                               
    收到其他与投资活动有关的现金                                                   1,684,655.27       1,454,587.98       
    投资活动现金流入小计                                                           3,842,120.27       4,874,102.16       
    购建固定资产、无形资产和其他长期资产支付的现金                                 6,920,514.96       11,310,918.33      
    投资支付的现金                                                                                    151,206,156.67     
    质押贷款净增加额                                                                                                     
    取得子公司及其他营业单位支付的现金净额                                                                               
    支付其他与投资活动有关的现金                                                                                         
    投资活动现金流出小计                                                           6,920,514.96       162,517,075.00     
    投资活动产生的现金流量净额                                                     -3,078,394.69      -157,642,972.84    
    三、筹资活动产生的现金流量:                                                                                         
    吸收投资收到的现金                                                                                                   
    其中:子公司吸收少数股东投资收到的现金                                                                               
    取得借款收到的现金                                                             434,350,000.00     466,150,000.00     
    发行债券收到的现金                                                                                                   
    收到其他与筹资活动有关的现金                                                                                         
    筹资活动现金流入小计                                                           434,350,000.00     466,150,000.00     
    偿还债务支付的现金                                                             434,150,000.00     464,337,432.20     
    分配股利、利润或偿付利息支付的现金                                             40,886,098.57      37,857,570.71      
    其中:子公司支付给少数股东的股利、利润                                         427,875.00         12,332,800.00      
    支付其他与筹资活动有关的现金                                                   440,530.00         995,000.00         
    筹资活动现金流出小计                                                           475,476,628.57     503,190,002.91     
    筹资活动产生的现金流量净额                                                     -41,126,628.57     -37,040,002.91     
    四、汇率变动对现金及现金等价物的影响                                           47,900.30          -4,532.92          
    五、现金及现金等价物净增加额                                                   35,192,438.81      -164,009,773.82    
    加:期初现金及现金等价物余额                                                   138,417,179.55     332,345,889.27     
    六、期末现金及现金等价物余额                                                   173,609,618.36     168,336,115.45     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海       主管会计工作负责人:吴亚君        会计机构负责人:陈礼英
     母公司现金流量表
    编制单位:武汉人福高科技产业股份有限公司                             单位:元      币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                               附注        本期金额           上期金额           
    一、经营活动产生的现金流量:                                                                                         
    销售商品、提供劳务收到的现金                                                   54,186,233.00      13,290,000.00      
    收到的税费返还                                                                                                       
    收到其他与经营活动有关的现金                                                   171,743,002.00     98,301,194.72      
    经营活动现金流入小计                                                           225,929,235.00     111,591,194.72     
    购买商品、接受劳务支付的现金                                                   24,331,062.05      19,674,220.09      
    支付给职工以及为职工支付的现金                                                 2,032,242.37       2,036,245.36       
    支付的各项税费                                                                 4,342,945.59       6,720.00           
    支付其他与经营活动有关的现金                                                   188,185,714.07     80,934,393.54      
    经营活动现金流出小计                                                           218,891,964.08     102,651,578.99     
    经营活动产生的现金流量净额                                                     7,037,270.92       8,939,615.73       
    二、投资活动产生的现金流量:                                                                                         
    收回投资收到的现金                                                             1,900,000.00       600,000.00         
    取得投资收益收到的现金                                                         15,157,800.00      1,000,000.00       
    处置固定资产、无形资产和其他长期资产收回的现金净额                             228,606.00         1,585,463.32       
    处置子公司及其他营业单位收到的现金净额                                                                               
    收到其他与投资活动有关的现金                                                   800,541.34         822,332.15         
    投资活动现金流入小计                                                           18,086,947.34      4,007,795.47       
    购建固定资产、无形资产和其他长期资产支付的现金                                 267,269.82         139,126.17         
    投资支付的现金                                                                                    111,510,616.87     
    取得子公司及其他营业单位支付的现金净额                                                                               
    支付其他与投资活动有关的现金                                                                                         
    投资活动现金流出小计                                                           267,269.82         111,649,743.04     
    投资活动产生的现金流量净额                                                     17,819,677.52      -107,641,947.57    
    三、筹资活动产生的现金流量:                                                                                         
    吸收投资收到的现金                                                                                                   
    取得借款收到的现金                                                             300,650,000.00     322,650,000.00     
    收到其他与筹资活动有关的现金                                                                                         
    筹资活动现金流入小计                                                           300,650,000.00     322,650,000.00     
    偿还债务支付的现金                                                             292,650,000.00     300,000,000.00     
    分配股利、利润或偿付利息支付的现金                                             23,302,650.65      15,706,865.63      
    支付其他与筹资活动有关的现金                                                   440,530.00         995,000.00         
    筹资活动现金流出小计                                                           316,393,180.65     316,701,865.63     
    筹资活动产生的现金流量净额                                                     -15,743,180.65     5,948,134.37       
    四、汇率变动对现金及现金等价物的影响                                                                                 
    五、现金及现金等价物净增加额                                                   9,113,767.79       -92,754,197.47     
    加:期初现金及现金等价物余额                                                   37,966,880.06      132,058,147.96     
    六、期末现金及现金等价物余额                                                   47,080,647.85      39,303,950.49      
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海      主管会计工作负责人:吴亚君        会计机构负责人:陈礼英 合并所有者权益变动表
    编制单位:武汉人福高科技产业股份有限公司                                                                                    单位:元      币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                   本期金额                                                                                      
    归属于母公司所有者权益                                                少数股东   所有者权益合 
    实收资本(   资本公积   减:库   盈余公积   一般风险   未分配利  其他  权益       计           
    或股本)                存股                准备       润                                      
    一、上年年末余额       389,085,68  255,483,7           63,143,02             227,864,        231,563,9  1,167,140,92 
    6.00        46.25               0.64                  557.48          13.09      3.46         
    加:会计政策变更                                                                                                     
    前期差错更正                                                                                                         
    二、本年年初余额       389,085,68  255,483,7           63,143,02             227,864,        231,563,9  1,167,140,92 
    6.00        46.25               0.64                  557.48          13.09      3.46         
    三、本期增减变动金额                                                         32,722,0        2,758,743  35,480,753.9 
                                      10.17           .81        8            
    (一)净利润                                                                 38,558,3        10,310,94  48,869,256.4 
                                      12.62           3.81       3            
    (二)直接计入所有者                                                                                                 
    权益的利得和损失                                                                                                     
    1.可供出售金融资产公                                                                                                
    允价值变动净额                                                                                                       
    2.权益法下被投资单位                                                                                                
    其他所有者权益变动的                                                                                                 
    影响                                                                                                                 
    3.与计入所有者权益项                                                                                                
    目相关的所得税影响                                                                                                   
    4.其他                                                                                                              
    上述(一)和(二)小                                                         38,558,3        10,310,94  48,869,256.4 
    计                                                                           12.62           3.81       3            
    (三)所有者投入和减                                                                                                 
    少资本                                                                                                               
    1.所有者投入资本                                                                                                    
    2.股份支付计入所有者                                                                                                
    权益的金额                                                                                                           
    3.其他                                                                                                              
    (四)利润分配                                                               -5,836,3        -7,552,20  -13,388,502. 
                                      02.45           0.00       45           
    1.提取盈余公积                                                                                                      
    2.提取一般风险准备                                                                                                  
    3.对所有者(或股东)                                                        -5,836,3        -7,552,20  -13,388,502. 
    的分配                                                                       02.45           0.00       45           
    4.其他                                                                                                              
    (五)所有者权益内部                                                                                                 
    结转                                                                                                                 
    1.资本公积转增资本(                                                                                                
    或股本)                                                                                                             
    2.盈余公积转增资本(                                                                                                
    或股本)                                                                                                             
    3.盈余公积弥补亏损                                                                                                  
    4.其他                                                                                                              
    四、本期期末余额       389,085,68  255,483,7           63,143,02             260,586,        234,322,6  1,202,621,67 
    6.00        46.25               0.64                  567.65          56.90      7.44         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
     单位:元 币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    上年同期金额                                                                                 
    归属于母公司所有者权益                                                少数股东  所有者权益合 
    实收资本(   资本公积   减:库   盈余公积   一般风险  未分配利   其他  权益      计           
    或股本)                存股                准备      润                                      
    一、上年年末余额        259,390,45  359,154,7           81,448,02            184,226,9        224,756,  1,108,976,62 
    7.00        93.95               2.51                 32.59            417.09    3.14         
    加:会计政策变更                                        783,694.9            -3,951,42        159,350.  -3,008,381.2 
                 4                    6.91             72        5            
    前期差错更正                                                                                                         
    二、本年年初余额        259,390,45  359,154,7           82,231,71            180,275,5        224,915,  1,105,968,24 
    7.00        93.95               7.45                 05.68            767.81    1.89         
    三、本期增减变动金额(                                                                                               
    减少以“-”号填列)                                                                                                 
    (一)净利润                                                                 26,460,68        7,093,02  33,553,714.5 
                                      8.01             6.53      4            
    (二)直接计入所有者权                                                                        -1,203,7  -1,203,728.5 
    益的利得和损失                                                                                28.58     8            
    1.可供出售金融资产公                                                                                                
    允价值变动净额                                                                                                       
    2.权益法下被投资单位                                                                                                
    其他所有者权益变动的影                                                                                               
    响                                                                                                                   
    3.与计入所有者权益项                                                                                                
    目相关的所得税影响                                                                                                   
    4.其他                                                                                       -1,203,7  -1,203,728.5 
                                                       28.58     8            
    上述(一)和(二)小计                                                       26,460,68        5,889,29  32,349,985.9 
                                      8.01             7.95      6            
    (三)所有者投入和减少                                                                        -7,432,9  -7,432,911.5 
    资本                                                                                          11.50     0            
    1.所有者投入资本                                                                             -7,432,9  -7,432,911.5 
                                                       11.50     0            
    2.股份支付计入所有者                                                                                                
    权益的金额                                                                                                           
    3.其他                                                                                                              
    (四)利润分配          25,939,045                                           -29,052,2        -900,000  -4,013,209.8 
    .70                                                  55.53            .00       3            
    1.提取盈余公积                                                                                                      
    2.提取一般风险准备                                                                                                  
    3.对所有者(或股东)   25,939,045                                           -29,052,2        -900,000  -4,013,209.8 
    的分配                  .70                                                  55.53            .00       3            
    4.其他                                                                                                              
    (五)所有者权益内部结  103,756,18  -103,756,                                                                        
    转                      3.30        183.30                                                                           
    1.资本公积转增资本(   103,756,18  -103,756,                                                                        
    或股本)                3.30        183.30                                                                           
    2.盈余公积转增资本(                                                                                                
    或股本)                                                                                                             
    3.盈余公积弥补亏损                                                                                                  
    4.其他                                                                                                              
    四、本期期末余额        389,085,68  255,398,6  0        82,231,71  0         177,683,9  0     222,472,  1,126,872,10 
    6.00        10.65               7.45                 38.16            154.26    6.52         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海                          主管会计工作负责人:吴亚君                                     会计机构负责人:陈礼英 母公司所有者权益变动表
    编制单位:武汉人福高科技产业股份有限公司                                                                                     单位:元      币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                      本期金额                                                                                   
    实收资本(或股  资本公积        减:库存股     盈余公积       未分配利润      所有者权益合  
    本)                                                                          计            
    一、上年年末余额          389,085,686.0  249,389,742.67                 63,143,020.64  119,089,129.92  820,707,579.2 
    0                                                                            3             
    加:会计政策变更                                                                                                     
    前期差错更正                                                                                                         
    二、本年年初余额          389,085,686.0  249,389,742.67                 63,143,020.64  119,089,129.92  820,707,579.2 
    0                                                                            3             
    三、本期增减变动金额(减                                                               19,187,362.27   19,187,362.27 
    少以“-”号填列)                                                                                                   
    (一)净利润                                                                           25,023,664.72   25,023,664.72 
    (二)直接计入所有者权益                                                                                             
    的利得和损失                                                                                                         
    1.可供出售金融资产公允                                                                                              
    价值变动净额                                                                                                         
    2.权益法下被投资单位其                                                                                              
    他所有者权益变动的影响                                                                                               
    3.与计入所有者权益项目                                                                                              
    相关的所得税影响                                                                                                     
    4.其他                                                                                                              
    上述(一)和(二)小计                                                                 25,023,664.72   25,023,664.72 
    (三)所有者投入和减少资                                                                                             
    本                                                                                                                   
    1.所有者投入资本                                                                                                    
    2.股份支付计入所有者权                                                                                              
    益的金额                                                                                                             
    3.其他                                                                                                              
    (四)利润分配                                                                         -5,836,302.45   -5,836,302.45 
    1.提取盈余公积                                                                                                      
    2.对所有者(或股东)的                                                                -5,836,302.45   -5,836,302.45 
    分配                                                                                                                 
    3.其他                                                                                                              
    (五)所有者权益内部结转                                                                                             
    1.资本公积转增资本(或                                                                                              
    股本)                                                                                                               
    2.盈余公积转增资本(或                                                                                              
    股本)                                                                                                               
    3.盈余公积弥补亏损                                                                                                  
    4.其他                                                                                                              
    四、本期期末余额          389,085,686.0  249,389,742.67                 63,143,020.64  138,276,492.19  839,894,941.5 
    0                                                                            0             
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
     单位:元 币种:人民币
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                      上年同期金额                                                                               
    实收资本(或股  资本公积        减:库存股     盈余公积       未分配利润      所有者权益合  
    本)                                                                          计            
    一、上年年末余额          259,390,457.0  359,154,793.95                 81,448,022.51  184,226,932.59  884,220,206.0 
    0                                                                            5             
    加:会计政策变更                                                        783,694.94     -3,951,426.91   -3,167,731.97 
    前期差错更正                                                                                                         
    二、本年年初余额          259,390,457.0  359,154,793.95                 82,231,717.45  180,275,505.68  881,052,474.0 
    0                                                                            8             
    三、本期增减变动金额(减                                                                                             
    少以“-”号填列)                                                                                                   
    (一)净利润                                                                           171,793.10      171,793.10    
    (二)直接计入所有者权益                                                                                             
    的利得和损失                                                                                                         
    1.可供出售金融资产公允                                                                                              
    价值变动净额                                                                                                         
    2.权益法下被投资单位其                                                                                              
    他所有者权益变动的影响                                                                                               
    3.与计入所有者权益项目                                                                                              
    相关的所得税影响                                                                                                     
    4.其他                                                                                                              
    上述(一)和(二)小计                                                                                               
    (三)所有者投入和减少资                                                                                             
    本                                                                                                                   
    1.所有者投入资本                                                                                                    
    2.股份支付计入所有者权                                                                                              
    益的金额                                                                                                             
    3.其他                                                                                                              
    (四)利润分配            25,939,045.70                                                -29,052,255.53  -3,113,209.83 
    1.提取盈余公积                                                                                                      
    2.对所有者(或股东)的   25,939,045.70                                                -29,052,255.53  -3,113,209.83 
    分配                                                                                                                 
    3.其他                                                                                                              
    (五)所有者权益内部结转  103,756,183.3  -103,756,183.3                                                              
    0              0                                                                           
    1.资本公积转增资本(或   103,756,183.3  -103,756,183.3                                                              
    股本)                    0              0                                                                           
    2.盈余公积转增资本(或                                                                                              
    股本)                                                                                                               
    3.盈余公积弥补亏损                                                                                                  
    4.其他                                                                                                              
    四、本期期末余额          389,085,686.0  255,398,610.65                 82,231,717.45  151,395,043.25  878,111,057.3 
    0                                                                            5             
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    法定代表人: 王学海                                 主管会计工作负责人:吴亚君                            会计机构负责人:陈礼英
     武汉人福高科技产业股份有限公司
    财 务 报 表 附 注
    金额单位:人民币元
    
    一、公司基本情况
    (一)公司简介
    武汉人福高科技产业股份有限公司(以下简称“公司”或“本公司”)经武汉市工商行政管理局注册登记,企业法人营业执照注册号:420100000011675。
    住    所:武汉市洪山区关山街鲁磨路369号
    法定代表人:王学海
    注册资本:(人民币)叁亿捌仟玖佰零捌万伍仟陆佰捌拾陆元
    经营范围:生物工程、电子、通信、新材料、光机电一体化等技术及产品的开发、研制、技术服务及咨询,开发产品的销售;百货、五金交电、计算机及配件、汽车配件、通信器材、机电产品零售兼批发;房地产开发、商品房销售(资质贰级);经营本公司及成员企业自产的机电产品、化工产品、五金矿产品及相关的出口业务;经营本公司及成员企业生产科研所需原辅料、机械设备、仪器仪表、零配件及相关技术的进口业务;组织“三来一补”业务;医疗器械(一、二、三类)销售;医用高分子材料及制品(二类)生产。
    (二)历史沿革
    武汉人福高科技产业股份有限公司(以下简称“公司”),是于1993年2月15日经武汉市经济体制改革委员会武体改[1993]217号文批准,由中国人福新技术开发中心、武汉市当代科技发展总公司(现改名为武汉当代科技产业集团股份有限公司)、武汉东湖新技术开发区发展总公司(现改名为武汉高科国有控股集团有限公司)共同发起并采用定向募集方式设立的股份有限公司。公司设立时股本为3,750万元。经中国证券监督管理委员会证监发[1997]240号文批准,公司于1997年在上海证券交易所公开发行2,000万股社会公众股,发行后公司总股本为5,750万元。1999年8月26日,经中国证券监督管理委员会证监发[1999]90号文批准,公司向全体股东以1998年末的总股本为基数,按10:3的比例配售新股,应配1,725万股,实际配售880万股,股本增至6,630万股。2000年8月,公司根据2000年度第一次临时股东大会决议,以2000年6月30日总股本6630万股为基数,向全体股东实施了每10股转增6股送红股3股(含税)、派送现金0.75元(含税),股本增至12,597万股。2002年5月29日,经中国证券监督管理委员会证监发[2002]55号文批准,公司向全体股东以2000年末的总股本为基数,按10:3的比例配售新股,应配售3,779.1万股,实际配售1,926.6万股,股本增至14,523.6万股。2003年5月,公司根据2002年年度股东大会决议,以2002年12月31日总股本14,523.6万股为基数,向全体股东实施了每10股转增3股送红股1股(含税)、派送现金0.25元(含税),股本增至20,333.04万股。2006年07月,经中国证券监督管理委员会证监发行字[2006]31号文件核准,公司向全体股东以2004年年末总股本20,333.04万股为基数,按10:3的比例配售新股,可配股份总数为60,999,120股,实际配售56,060,057股,股本增至259,390,457股。2007年6月,公司根据2006年年度股东大会决议,以2006年12月31日总股本259,390,457股为基数,向全体股东实施了每10股转增4股送红股1股(含税)、派送现金0.12元(含税),股本增至389,085,686股。
    
    二、遵循企业会计准则的声明
    本公司声明:公司按照财务报表附注之三“财务报表的编制基础与方法”编制的财务报表符合企业会计准则的要求,在所有重大方面真实、公允、完整地反映了公司的财务状况、经营成果和现金流量。
    
    三、财务报表的编制基础与方法
    本公司2007年前实际执行财政部颁布的《企业会计制度》和《企业会计准则》。财政部于2006年颁布了《企业会计准则—基本准则》和《企业会计准则第1号—存货》等38项具体会计准则、应用指南,以及其后颁布的《企业会计准则解释第1号》等补充规定,形成了新的企业会计准则体系,公司从2007年1月1日起全面执行新的企业会计准则体系。在编制财务报表时,根据证监会会计字〔2007〕10号《公开发行证券的公司信息披露规范问答第7号—新旧会计准则过渡期间比较财务会计信息的编制和披露》规定,本公司以2007年1月1日作为执行企业会计准则体系的首次执行日,确认2007年1月1日资产负债表的期初数,并以此为基础,分析《企业会计准则第38号—首次执行企业会计准则》第五条至第十九条和《企业会计准则解释第1号》对可比期间利润表和可比期初资产负债表的影响,按照追溯调整的原则,将调整后的可比期间利润表和资产负债表作为本次申报财务报表,同时对相关财务报表项目按照《企业会计准则第30号—财务报表列报》、《企业会计准则第33号—合并财务报表》的规定进行了重新分类列报。
    本公司财务报表以持续经营为编制基础。
    
    四、公司主要会计政策、会计估计
    (一)会计期间
    会计年度自公历1月1日起至12月31日止。
    (二)记账本位币
    采用人民币为记账本位币。
    (三)会计计量属性
    财务报表项目以历史成本计量为主。以公允价值计量且其变动记入当期损益的金融资产和金融负债、可供出售金融资产和衍生金融工具等以公允价值计量;采购时超过正常信用条件延期支付的存货、固定资产等,以购买价款的现值计量;发生减值损失的存货以可变现净值计量,其他减值资产按可收回金额(公允价值与现值孰高)计量;盘盈资产等按重置成本计量。
    本报告期各财务报表项目会计计量属性未发生变化。
    (四)现金等价物的确定标准
    现金等价物是指企业持有的期限短(一般是指从购买日起3个月内到期)、流动性强、易于转换为已知金额现金、价值变动风险很小的投资。
    (五)外币折算
    对发生的外币业务,按照交易发生日的即期汇率折合人民币记账。对各种外币账户的外币期末余额,外币货币性项目按资产负债表日即期汇率折算,发生的差额计入当期损益;以历史成本计量的外币非货币性项目仍采用交易发生日的即期汇率折算;以公允价值计量的外币非货币性项目,采用公允价值确定日的即期汇率折算,差额作为公允价值变动损益。
    外币财务报表的折算遵循下列原则:
    1、资产负债表中的资产和负债项目,采用资产负债表日的即期汇率折算;所有者权益项目除“未分配利润”项目外,其他项目采用发生时的即期汇率折算;
    2、利润表中的收入和费用项目,按照交易发生日的即期汇率近似的汇率折算;
    3、按照上述折算产生的外币财务报表折算差额,在资产负债表中所有者权益项目下单独列示;
    4、现金流量表按照交易发生日的即期汇率折算。汇率变动对现金的影响额作为调节项目,在现金流量表中单独列示。
    (六)金融工具的确认和计量
    1、金融资产和金融负债的分类
    金融资产在初始确认时划分为以下四类:以公允价值计量且其变动计入当期损益的金融资产(包括交易性金融资产和指定为以公允价值计量且其变动计入当期损益的金融资产)、持有至到期投资、贷款和应收款项、可供出售金融资产。
    金融负债在初始确认时划分为以下两类:以公允价值计量且其变动计入当期损益的金融负债(包括交易性金融负债和指定为以公允价值计量且其变动计入当期损益的金融负债)、其他金融负债。
    2、金融资产和金融负债的确认依据和计量方法
    公司成为金融工具合同的一方时,确认一项金融资产或金融负债。初始确认金融资产或金融负债时,按照公允价值计量;对于以公允价值计量且其变动计入当期损益的金融资产和金融负债,相关交易费用直接计入当期损益;对于其他类别的金融资产或金融负债,相关交易费用计入初始确认金额。
    公司按照公允价值对金融资产进行后续计量,且不扣除将来处置该金融资产时可能发生的交易费用,但下列情况除外:(1) 持有至到期投资以及贷款和应收款项采用实际利率法,按摊余成本计量;(2) 在活跃市场中没有报价且其公允价值不能可靠计量的权益工具投资,以及与该权益工具挂钩并须通过交付该权益工具结算的衍生金融资产,按照成本计量。
    公司采用实际利率法,按摊余成本对金融负债进行后续计量,但下列情况除外:(1)以公允价值计量且其变动计入当期损益的金融负债,按照公允价值计量,且不扣除将来结清金融负债时可能发生的交易费用;(2)与在活跃市场中没有报价、公允价值不能可靠计量的权益工具挂钩并须通过交付该权益工具结算的衍生金融负债,按照成本计量;(3)不属于指定为以公允价值计量且其变动计入当期损益的金融负债的财务担保合同,或没有指定为以公允价值计量且其变动计入当期损益并将以低于市场利率贷款的贷款承诺,按照履行相关现时义务所需支出的最佳估计数与初始确认金额扣除按照实际利率法摊销的累计摊销额后的余额两项金额之中的较高者进行后续计量。
    3、金融资产转移的确认依据和计量方法
    公司已将金融资产所有权上几乎所有的风险和报酬转移给了转入方的,终止确认该金融资产;保留了金融资产所有权上几乎所有的风险和报酬的,继续确认所转移的金融资产,并将收到的对价确认为一项金融负债。公司既没有转移也没有保留金融资产所有权上几乎所有的风险和报酬的,分别下列情况处理:(1)放弃了对该金融资产控制的,终止确认该金融资产;(2)未放弃对该金融资产控制的,按照继续涉入所转移金融资产的程度确认有关金融资产,并相应确认有关负债。
    金融资产整体转移满足终止确认条件的,将下列两项金额的差额计入当期损益:(1)所转移金融资产的账面价值;(2)因转移而收到的对价,与原直接计入所有者权益的公允价值变动累计额之和。金融资产部分转移满足终止确认条件的,将所转移金融资产整体的账面价值,在终止确认部分和未终止确认部分之间,按照各自的相对公允价值进行分摊,并将下列两项金额的差额计入当期损益:(1)终止确认部分的账面价值;(2)终止确认部分的对价,与原直接计入所有者权益的公允价值变动累计额中对应终止确认部分的金额之和。
    4、主要金融资产和金融负债的公允价值确定方法
    存在活跃市场的金融资产或金融负债,以活跃市场的报价确定其公允价值;不存在活跃市场的金融资产或金融负债,采用估值技术(包括参考熟悉情况并自愿交易的各方最近进行的市场交易中使用的价格、参照实质上相同的其他金融工具的当前公允价值、现金流量折现法和期权定价模型等)确定其公允价值;初始取得或源生的金融资产或承担的金融负债,以市场交易价格作为确定其公允价值的基础。
    5、金融资产的减值测试和减值准备计提方法
    资产负债表日对以公允价值计量且其变动计入当期损益的金融资产以外的金融资产进行减值测试。对单项金额重大的金融资产单独进行减值测试;对单项金额不重大的金融资产,包括在具有类似信用风险特征的金融资产组合中进行减值测试;单独测试未发生减值的金融资产(包括单项金额重大和不重大的金融资产),包括在具有类似信用风险特征的金融资产组合中进行减值测试。
    按摊余成本计量的金融资产,期末有客观证据表明其发生了减值的,根据其账面价值与预计未来现金流量现值之间的差额计算确认减值损失,短期应收款项的预计未来现金流量与其现值相差很小的,在确定相关减值损失时,不对其预计未来现金流量进行折现。在活跃市场中没有报价且其公允价值不能可靠计量的权益工具投资,或与该权益工具挂钩并须通过交付该权益工具结算的衍生金融资产发生减值时,将该权益工具投资或衍生金融资产的账面价值,与按照类似金融资产当时市场收益率对未来现金流量折现确定的现值之间的差额,确认为减值损失。可供出售金融资产的公允价值发生较大幅度下降且预期下降趋势属于非暂时性时,确认其减值损失,并将原直接计入所有者权益的公允价值累计损失一并转出计入减值损失。
    (七)应收款项坏账准备的计提方法
    对于单项金额重大且有客观证据表明发生了减值的应收款项(包括应收账款和其他应收款),根据其未来现金流量现值低于其账面价值的差额计提坏账准备;对于单项金额非重大以及经单独测试后未减值的单项金额重大的应收款项(包括应收账款和其他应收款),根据相同账龄应收款项组合的实际损失率为基础,结合现时情况确定报告期各项组合计提坏账准备的比例。确定具体提取比例为:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄                                                                  计提比例(%)                                  
    1年以内(含1年,以下类推)                                            3                                              
    1-2年                                                                 5                                              
    2-3年                                                                 10                                             
    3-4年                                                                 30                                             
    4-5年                                                                 60                                             
    5年以上                                                               100                                            
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    对有确凿证据表明可收回性存在明显差异的应收款项,采用个别认定法计提坏账准备。
    (八)存货
    1、存货的分类:主要包括原材料、在产品、产成品、库存商品、开发产品、开发成本、低值易耗品。
    2、存货计价方法:存货购进按实际成本计价,发出或领用时采用加权平均法计价;存货期末按成本与可变现净值孰低计价。包装物、低值易耗品和其他周转材料采用一次转销法进行摊销。
    3、存货盘存制度采用永续盘存制。
    4、期(年)末,存货按成本与可变现净值(存货可变现净值的确定方法是以存货的估计售价减去至完工时将要发生的成本、销售费用以及相关税费后的金额,并且考虑持有的目的、资产负债表日后事项的影响因素等按照相关规定分别选择合同价格、一般销售价格和市场价格确定存货的可变现净值)孰低法计价,对单项存货进行清查,如果由于存货毁损、全部或部分陈旧过时或销售价格低于成本等原因,使存货成本高于可变现净值的,按可变现净值低于个别成本的差额计提存货跌价准备。
    (九)长期股权投资的确认和计量
    1、长期股权投资初始投资成本的确定:
    (1)同一控制下的企业合并形成的,合并方以支付现金、转让非现金资产、承担债务或发行权益性证券作为合并对价的,在合并日按照取得被合并方所有者权益账面价值的份额作为其初始投资成本。长期股权投资初始投资成本与支付的合并对价的账面价值或发行股份的面值总额之间的差额调整资本公积;资本公积不足冲减的,调整留存收益。
    (2)非同一控制下的企业合并形成的,在购买日按照支付的合并对价的公允价值和各项直接相关费用作为其初始投资成本。
    (3)除企业合并形成以外的:以支付现金取得的,按照实际支付的购买价款作为其初始投资成本;以发行权益性证券取得的,按照发行权益性证券的公允价值作为其初始投资成本;投资者投入的,按照投资合同或协议约定的价值作为其初始投资成本(合同或协议约定价值不公允的除外)。
    2、对实施控制的长期股权投资采用成本法核算,在编制合并财务报表时按照权益法进行调整;对不具有共同控制或重大影响,并且在活跃市场中没有报价、公允价值不能可靠计量的长期股权投资,采用成本法核算;对具有共同控制或重大影响的长期股权投资,采用权益法核算。
    3、资产负债表日,以成本法核算的、在活跃市场中没有报价、公允价值不能可靠计量的长期股权投资,有客观证据表明其发生减值的,按照类似投资当时市场收益率对预计未来现金流量折现确定的现值低于其账面价值之间的差额,计提长期投资减值准备;其他投资,当存在减值迹象时,按资产减值所述方法计提长期投资减值准备。
    4、确定对被投资单位具有共同控制、重大影响的依据:按照合同约定,与被投资单位相关的重要财务和经营决策需要分享控制权的投资方一致同意的,认定为共同控制;对被投资单位的财务和经营政策有参与决策的权力,但并不能够控制或者与其他方一起共同控制这些政策的制定的,认定为重大影响。
    (十)投资性房地产的确认和计量
    1、投资性房地产包括已出租的土地使用权、持有并准备增值后转让的土地使用权、已出租的建筑物。
    2、投资性房地产按照成本进行初始计量,采用成本模式进行后续计量。
    3、对成本模式计量的投资性房地产,采用与固定资产和无形资产相同的方法计提折旧或进行摊销。
    4、以成本模式计量的投资性房地产,在资产负债表日有迹象表明投资性房地产发生减值的,按资产减值所述方法计提投资性房地产减值准备。
    (十一)固定资产的确认和计量
    1、固定资产是指同时具有下列特征的有形资产:(1)为生产商品、提供劳务、出租或经营管理持有的;(2)使用寿命超过一个会计年度。
    2、固定资产同时满足下列条件的予以确认:(1)与该固定资产有关的经济利益很可能流入企业;(2)该固定资产的成本能够可靠地计量。与固定资产有关的后续支出,符合上述确认条件的,计入固定资产成本;不符合上述确认条件的,发生时计入当期损益。
    符合下列一项或数项标准的,认定为融资租赁:(1)在租赁期届满时,租赁资产的所有权转移给承租人;(2)承租人有购买租赁资产的选择权,所订立的购买价款预计将远低于行使选择权时租赁资产的公允价值,因而在租赁开始日就可以合理确定承租人将会行使这种选择权;(3)即使资产的所有权不转移,但租赁期占租赁资产使用寿命的大部分[通常占租赁资产使用寿命的75%以上(含75%)];(4)承租人在租赁开始日的最低租赁付款额现值,几乎相当于租赁开始日租赁资产公允价值[90%以上(含90%)];出租人在租赁开始日的最低租赁收款额现值,几乎相当于租赁开始日租赁资产公允价值[90%以上(含90%)];(5)租赁资产性质特殊,如果不作较大改造,只有承租人才能使用。
    3、固定资产按照成本进行初始计量。融资租入的固定资产,按租赁开始日租赁资产的公允价值与最低租赁付款额的现值中较低者入账,按自有固定资产的折旧政策计提折旧。
    4、固定资产折旧采用年限平均法。各类固定资产的使用寿命、预计净残值和年折旧率如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    固定资产类别                          使用年限(年)               净残值率(%)               年折旧率(%)               
    房屋建筑物                            30-50                      3                         3.23-1.94                 
    机器设备                              8-14                       5                         11.88-6.79                
    运输设备                              8-12                       5                         11.88-7.92                
    其他设备                              5-12                       5                         19.00-7.92                
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    5、因开工不足、自然灾害等导致连续6个月停用的固定资产确认为闲置固定资产(季节性停用除外)。闲置固定资产采用和其他同类别固定资产一致的折旧方法。
    6、资产负债表日,有迹象表明固定资产发生减值的,按资产减值所述方法计提固定资产减值准备。
    (十二)在建工程
    在建工程是指购建固定资产使工程达到预定可使用状态前所发生的必要支出,包括工程直接材料、直接职工薪酬、待安装设备、工程建筑安装费、工程管理费和工程试运转净损益以及允许资本化的借款费用等。
    在建工程在达到预定可使用状态时转入固定资产。
    资产负债表日,有迹象表明在建工程发生减值的,按资产减值所述方法计提在建工程减值准备。
    (十三)无形资产
    1、初始确认
    本公司的无形资产包括土地使用权、商标权、采矿权等。
    无形资产按照成本进行初始计量。
    2、后续计量
    使用寿命有限的无形资产,其应摊销金额在使用寿命内系统合理摊销,计入当期损益。无法可靠确定预期实现方式的,采用直线法摊销。
    本公司至少于每年年度终了,对使用寿命有限的无形资产的使用寿命及摊销方法进行复核,必要时进行调整。
    无法预见无形资产带来经济利益的期限的作为使用寿命不确定的无形资产。使用寿命不确定的无形资产不摊销,但每年均对该无形资产的使用寿命进行复核,并进行减值测试。
    资产负债表日,有迹象表明无形资产发生减值的,按资产减值所述方法计提无形资产减值准备。
    3、使用寿命的估计
    对使用寿命有限的无形资产,估计其使用寿命时通常考虑以下因素:
    (1)运用该资产生产的产品通常的寿命周期、可获得的类似资产使用寿命的信息;
    (2)技术、工艺等方面的现阶段情况及对未来发展趋势的估计;
    (3)以该资产生产的产品或提供劳务的市场需求情况;
    (4)现在或潜在的竞争者预期采取的行动;
    (5)为维持该资产带来经济利益能力的预期维护支出,以及公司预计支付有关支出的能力;
    (6)对该资产控制期限的相关法律规定或类似限制,如特许使用期、租赁期等;
    (7)与公司持有其他资产使用寿命的关联性等。
    4、研究阶段和开发阶段的划分
    内部研究开发项目研究阶段的支出,于发生时计入当期损益。
    内部研究开发项目开发阶段的支出,同时满足下列条件的,确认为无形资产:
    (1)完成该无形资产以使其能够使用或出售在技术上具有可行性;
    (2)具有完成该无形资产并使用或出售的意图;
    (3)无形资产产生经济利益的方式,包括能够证明运用该无形资产生产的产品存在市场或无形资产自身存在市场,无形资产将在内部使用的,可证明其有用性;
    (4)有足够的技术、财务资源和其他资源支持,以完成该无形资产的开发,并有能力使用或出售该无形资产;
    (5)归属于该无形资产开发阶段的支出能够可靠地计量。
    (十四)资产减值
    1、资产负债表日,有迹象表明资产(除存货、采用公允价值模式计量的投资性房地产、消耗性生物资产、建造合同形成的资产、递延所得税资产、融资租赁中出租人未担保余值和金融资产以外)发生减值的,以单项资产为基础估计其可收回金额;难以对单项资产的可收回金额进行估计的,以该资产所属的资产组或资产组组合为基础确定其可收回金额。
    2、可收回金额根据单项资产、资产组或资产组组合的公允价值减去处置费用后的净额与该单项资产、资产组或资产组组合的预计未来现金流量的现值两者之间较高者确定。
    3、资产组是公司认定的最小资产组合,其产生的现金流入基本上独立于其他资产或资产组。资产组组合是由若干个资产组组成的最小资产组组合,包括资产组或资产组组合,以及按合理方法分摊的总部资产部分。
    4、单项资产的可收回金额低于其账面价值的,按单项资产的账面价值与可收回金额的差额计提相应的资产减值准备。资产组或资产组组合的可收回金额低于其账面价值的,确认其相应的减值损失,减值损失金额先抵减分摊至资产组或资产组组合中商誉的账面价值,再根据资产组或资产组组合中除商誉之外的其他各项资产的账面价值所占比重,按比例抵减其他各项资产的账面价值;以上资产账面价值的抵减,作为各单项资产(包括商誉)的减值损失,计提各单项资产的减值准备。
    上述资产减值损失一经确认,在以后会计期间不予转回。
    (十五)企业合并
    1、同一控制下的企业合并
    对于同一控制下的企业合并,本公司采用权益结合法进行会计处理。合并取得的被合并方的资产、负债,除因会计政策不同而进行的调整以外,按原账面价值计量,不形成商誉。合并对价的账面价值,与合并中取得的净资产账面价值份额的差额,调整资本公积,资本公积不足冲减的,调整留存收益。被合并方在合并前的净利润,纳入合并利润表。
    2、非同一控制下的企业合并
    本公司对购买方合并成本大于合并中取得的被购买方可辨认净资产公允价值份额的差额,确认为商誉,按成本扣除累计减值准备后的金额计量;对合并成本小于合并中取得的被购买方可辨认净资产公允价值份额的差额,经复核后计入当期损益。
    被购买方的经营成果自本公司取得控制权之日起合并,直至其控制权自本公司内转出。
    (十六)借款费用
    1、借款费用是指本公司因借款而发生的利息及其他相关成本,包括借款利息、折价或者溢价的摊销、辅助费用以及因外币借款而发生的汇兑差额等。
    2、可直接归属于符合资本化条件的资产的购建或者生产的借款费用,予以资本化,其他借款费用计入当期损益。符合资本化条件的资产是指需要经过相当长时间的购建或者生产活动才能达到预定可使用或者可销售状态的固定资产、投资性房地产和存货等资产。
    (1)借款费用同时满足下列条件的,才能开始资本化:
    A、资产支出已经发生;
    B、借款费用已经发生;
    C、为使资产达到预定可使用或者可销售状态所必要的购建或者生产活动已经开始。
    (2)购建或者生产符合资本化条件的资产达到预定可使用或者可销售时,借款费用停止资本化。之后发生的借款费用计入当期损益。
    符合资本化条件的资产在购建或者生产过程中发生非正常中断,且中断时间连续超过3个月,暂停借款费用的资本化,暂停期间发生的借款费用计入当期损益。
    (3)在资本化期间内,每一会计期间的利息资本化金额,按照下列方法确定:
    A、专门借款以当期实际发生的利息费用,减去暂时性的存款利息收入或投资收益后的金额确定。
    B、占用的一般借款,根据累计资产支出超过专门借款部分的资产支出加权平均数乘以所占用一般借款的资本化率计算确定。资本化率根据一般借款加权平均利率计算确定。
    (十七)预计负债
    与或有事项相关的义务同时符合下列条件的,本公司将其确认为预计负债:
    1、该义务是本公司承担的现时义务;
    2、履行该义务很可能导致经济利益流出本公司;
    3、该义务的金额能够可靠地计量。
    (十八)股份支付
    1、股份支付是指本公司为获取职工和其他方提供服务而授予权益工具或者承担以权益工具为基础确定的负债的交易,包括以权益结算和以现金结算两种方式。
    2、以权益结算方式换取职工提供服务的,按照授予职工权益工具的公允价值计量;换取其他方服务的,按照其他方服务在取得日的公允价值计量,若其他方服务的公允价值不能可靠计量,按照权益工具在服务取得日的公允价值计量。
    3、权益工具的公允价值按照以下方法确定:
    (1)存在活跃市场的,按照活跃市场中的报价确定;
    (2)不存在活跃市场的,采用合理的估值技术确定,包括参考熟悉情况并自愿交易的各方最近进行的市场交易中使用的价格、参照实质上相同的其他金融工具的当前公允价值、现金流量折现法和期权定价模型等。
    4、以现金结算方式的,按照承担的以股份或其他权益工具为基础计算确定的负债的公允价值计量。
    5、根据最新取得可行权职工数变动等后续信息进行估计确定可行权权益工具最佳估计数。
    (十九)收入
    1、销售商品收入,在下列条件均能满足时确认:
    (1)企业已将商品所有权上的主要风险和报酬转移给购货方;
    (2)企业既没有保留通常与所有权相联系的继续管理权,也没有对已售出的商品实施控制;
    (3)收入的金额能够可靠地计量;
    (4)相关的经济利益很可能流入企业;
    (5)相关的已发生或将发生的成本能够可靠地计量。
    2、提供劳务收入的确认
    (1)在资产负债表日能够可靠估计交易的完工进度和交易的结果,且交易中已发生和将发生的成本能够可靠地计量的情况下,采用完工百分比法确认提供劳务收入,按已经发生的成本占估计总成本的比例确定完工进度。
    (2)在资产负债表日不能够可靠估计交易结果的,若已经发生的劳务成本预计能够得到补偿,按照已经发生的劳务成本金额确认提供劳务收入,并按相同金额结转劳务成本;若已经发生的劳务成本预计不能够得到补偿,将已经发生的劳务成本计入当期损益,不确认劳务收入。
    3、让渡资产使用权收入的确认
    (1)相关的经济利益很可能流入企业;
    (2)收入的金额能够可靠地计量。
    利息收入按照他人使用本公司货币资金的时间和实际利率计算确定;使用费收入按照有关合同或协议约定的收费时间和方法计算确定。
    4、建造合同
    (1)建造合同的结果在资产负债表日能够可靠估计的,根据完工百分比法确认合同收入和合同费用。建造合同的结果在资产负债表日不能够可靠估计的,若合同成本能够收回的,合同收入根据能够收回的实际合同成本予以确认,合同成本在其发生的当期确认为合同费用;若合同成本不可能收回的,在发生时立即确认为合同费用,不确认合同收入。
    (2)建造合同在同时满足下列条件的情况下,表明其结果能够可靠估计:
    A、与合同相关的经济利益很可能流入企业;
    B、实际发生的合同成本能够清楚地区分和可靠地计量;
    C、固定造价合同还必须同时满足合同总收入能够可靠计量及合同完工进度和为完成合同尚需发生的成本能够可靠地确定。
    (3)本公司按累计实际发生的合同成本占合同预计总成本的比例确定合同完工进度。
    (4)资产负债表日,合同预计总成本超过合同总收入的,将预计损失确认为当期费用。
    (二十)所得税
    1、本公司所得税的会计处理采用资产负债表债务法。
    2、所得税包括当期所得税和递延所得税。除由于企业合并产生的所得税调整商誉,或因直接计入所有者权益的交易或者事项产生的所得税计入所有者权益外,均作为所得税费用或收益计入当期损益。
    3、本公司以很可能取得用来抵扣可抵扣暂时性差异的应纳税所得额为限,确认由可抵扣暂时性差异产生的递延所得税资产,除非可抵扣暂时性差异是在以下交易中产生的:该项交易不是企业合并,并且交易发生时既不影响会计利润也不影响应纳税所得额(或可抵扣亏损)。
    资产负债表日,有确凿证据表明未来期间很可能获得足够的应纳税所得额用来抵扣可抵扣暂时性差异的,应当确认以前期间未确认的递延所得税资产。
    4、本公司于资产负债表日,对递延所得税资产的账面价值进行复核。如果未来期间很可能无法获得足够的应纳税所得额用以抵扣递延所得税资产的利益,减记递延所得税资产的账面价值。在很可能获得足够的应纳税所得额时,减记的金额予以转回。
    (二十一)政府补助
    政府补助在合理确保可收取且能满足政府补助所附条件的情况下,按其公允价值予以确认。对与收益相关的政府补助如用于补偿以后期间的相关费用或损失的,确认为递延收益,并在确认相关费用或损失的期间,计入当期损益。与资产相关的政府补助,确认为递延收益,并在相关资产使用寿命内平均分配,计入当期损益。
    (二十二)合并财务报表
    1、合并范围的确定原则
    本公司以控制为基础确定合并范围,将直接或通过子公司间接拥有被投资单位半数以上的表决权,或虽不足半数但能够控制的被投资单位,纳入合并财务报表的范围。
    2、合并财务报表的编制方法
    合并财务报表以母公司和子公司的个别财务报表为基础,根据有关资料,按照权益法调整对子公司的长期股权投资后,由母公司编制。合并时公司内部的所有重大交易和资金往来予以抵销。此外,本公司及其子公司在报告期内采用一致的会计政策和会计估计。
    
    五、会计政策和会计估计变更的说明
    (一)会计政策变更的说明
    报告期内,公司无会计政策变更事项。
    (二)会计估计变更
    报告期内,公司无会计估计变更事项。
    
    六、主要税项
    (一)各种税收税率
    1、增值税:天津中生乳胶有限公司、湖北葛店人福药业有限责任公司生产的计生用品的增值税率为零;武汉人福药业有限责任公司生产的生物制品的增值税按6%征收率计提并缴纳;其他公司按应税收入的17%计提,扣除符合规定的进项税后缴纳。
    2、营业税:湖北南湖当代学生公寓物业有限公司免征营业税;广州贝龙环保热力设备股份有限公司按应税收入的3%,其余按5%计提并缴纳。
    3、城市维护建设税:按应纳增值税额、营业税额的7%计提并缴纳。
    4、教育费附加:按应纳增值税额、营业税额的3%计提并缴纳。
    5、堤防费:按应纳增值税额、营业税额的2%计提并缴纳。
    6、平抑物价基金:按营业收入的1‰计提并缴纳。
    7、教育发展基金:按营业收入的1‰计提并缴纳。
    8、所得税:
    湖北南湖当代学生公寓物业有限公司、新疆维吾尔药业有限责任公司免征企业所得税。
    武汉当代物业发展有限公司经武汉市地方税务局东湖新技术开发区分局审核,自2003年起,征税方式由原查帐征收改为核定征收。
    其他公司按25%的税率预缴所得税。
    
    (二)税收优惠
    1、增值税:天津中生乳胶有限公司、湖北葛店人福药业有限责任公司生产的计生用品的增值税率为零;武汉人福药业有限责任公司生产的生物制品的增值税按6%征收率计提并缴纳。
    2、营业税:湖北南湖当代学生公寓物业有限公司根据财政部、国家税务总局财税字[2000]25号文《关于高校后勤社会化改革有关税收政策的通知》免征营业税;广州贝龙环保热力设备股份有限公司按应税收入的3%计提并缴纳。
    3、所得税:
    湖北南湖当代学生公寓物业有限公司根据财政部、国家税务总局财税字[2000]25号文《关于高校后勤社会化改革有关税收政策的通知》免征企业所得税。
    新疆维吾尔药业有限责任公司根据新疆维吾尔自治区地方税务局乌地税函《关于新疆维尔药业有限责任公司享受区外投资企业所得税优惠政策期间问题的通知》(乌地税函〔2005〕187号)文规定:2004年9月-2009年8月免征所得税。
    
    七、企业合并及合并财务报表
    (一)纳入合并范围内子公司的基本情况
    1、同一控制下的企业合并取得的子公司
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    序  公司名称             注册地                  组织机构  公司性   注册资   经营范围      公司投  持股   表决   级  
    号                                               代码      质       本(万                 资额(  比例   权比   次  
                             元)                   万元)  (%)  例(%      
                                                                   )         
    1   湖北南湖当代学生公   武汉市洪山区鲁磨路369#  72202315  有限责   13,000.  学生公寓开发  12,800  98.46  98.46  二  
    寓物业有限公司                               -9        任公司   00       、经营        .00     15     15         
    2   深圳新鹏生物工程技   深圳市南山区高新北区郎  19221097  有限责   10,000.  生产经营生物  5,200.  52.00  52.00  二  
    术有限公司           山二路新鹏生物园        -6        任公司   00       工程产品      00                        
    3   天津中生乳胶有限公   天津市空港物流加工区西  73848063  有限责   6,370.7  计生用品等开  5,733.  90.00  90.00  二  
    司                   十四道223号             -7        任公司   2        发、销售      65                        
    4   武汉天润健康产品有   武汉市洪山区鲁磨路369#  74476186  有限责   500.00   健康产品零售  450.00  90.00  90.00  二  
    限公司                                       -5        任公司            兼批发                                  
    5   武汉康诚医药销售有   武汉市洪山区珞珈山路特  27193100  有限责   1,250.0  西药、中药批  1,220.  97.60  97.60  三  
    限公司               1号                     -X        任公司   0        发            00                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、非同一控制下的企业合并取得的子公司
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    序  公司名称              注册地                  组织机  公司性质  注册   经营范围       公司投  持股   表决   级次 
    号                                                构代码            资本                  资额(  比例   权比        
                             (万                  万元)  (%)  例(%       
                             元)                                 )          
    1   广州贝龙环保热力设备  广州市白云区龙归镇夏良  231268  股份有限  3,500  制造加工       2,030.  58.00  58.00  二   
    股份有限公司          村                      38-9    公司      .00                   00                         
    2   武汉华山人福药业有限  武汉市江岸区胜利街168   728285  有限责任  2,000  西药、中药批   980.00  49.00  49.00  二   
    责任公司              号扶轮大厦16层          20-5    公司      .00    发                                        
    3   武汉康乐药业股份有限  武汉市经济技术开发区Ⅲ  300244  股份有限  3,200  中成药品、滋   3,200.  100.0  100.0  二   
    公司                  -4地块                  59-2    公司      .00    补保健药品、   00      0      0           
                                    药酒及西药制                              
                                    剂制造                                    
    4   武汉人福益民医药有限  武汉市洪山区鲁磨路111   717967  有限责任  533.3  医药销售       373.33  70.00  70.00  二   
    公司                  号                      54-2    公司      3                                                
    5   武汉人福药业有限责任  武汉市武昌区涂家岭7号   300196  有限责任  5,000  医药制造销售   5,000.  100.0  100.0  二   
    公司                                          67-4    公司      .00                   00      0      0           
    6   宜昌人福药业有限责任  湖北宜昌市开发区大连路  730843  有限责任  18,04  医药制造销售   12,631  70.00  70.00  二   
    公司                  18号                    40-5    公司      5.00                  .50                        
    7   中国联合生物技术有限  深圳市南山区高新北区郎  100008  有限责任  13,20  医药制造销售   8,712.  66.00  66.00  二   
    公司                  山二路新鹏生物园        29-6    公司      0.00                  00                         
    8   北京迈福维尔医药科技  北京市西城区西直门外大  665616  有限责任  800.0  医药销售       520.00  65.00  65.00  三   
    有限公司              街1号院1号              73-1    公司      0                                                
    9   广州贝龙环保热力销售  广州市白云区新广从路东  716329  有限责任  100.0  批发零售制冷   80.00   80.00  80.00  三   
    有限公司              方明珠花苑              51-4    公司      0      、制热普通机                              
                                    械设备及零配                              
                                    件                                        
    10  湖北华光制药有限责任  汉川中洲农场益光路1号   726107  有限责任  600.0  中成药加工     336.00  56.00  56.00  三   
    公司                                          51-X    公司      0                                                
    11  上海飞盾贸易有限公司  上海市沪太路7258号      747614  有限责任  50.00  计生用品销售   35.00   70.00  70.00  三   
           49X     公司                                                       
    12  中生爱佳药具发展有限  北京市朝阳区建国路93号  726340  有限责任  1,000  销售生殖健康   700.00  70.00  70.00  三   
    公司                  院4-3001                18-6    公司      .00    产品、医疗器                              
                                    械;货物进出                              
                                    口、技术进出                              
                                    口、代理进出                              
                                    口                                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    3、其他方式取得的子公司
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    序  公司名称            注册地          组织机构  公司性质   注册资   经营范围          公司投资  持股  表决权  级次 
    号                                      代码                 本(万                     额(万元  比例  比例(       
                      元)                       )        (%   %)          
                                                           )                 
    1   湖北葛店人福药业有  湖北葛店经济技  72611849  有限责任   6,648.7  医药制造销售      6,648.70  100.  100.00  二   
    限责任公司          术开发区内      -7        公司       0                                    00                 
    2   武汉当代物业发展有  武汉市洪山区鲁  30009445  有限责任   6,000.0  房地产开发        5,100.00  85.0  85.00   二   
    限公司              磨路369#        -9        公司       0                                    0                  
    3   武汉人福医用光学电  武汉市洪山区鲁  71193310  有限责任   500.00   开发、研制医疗器  350.00    70.0  70.00   二   
    子有限公司          磨路369#        -6        公司                械、电子产品                0                  
    4   新疆维吾尔药业有限  乌鲁木齐市沈阳  72694867  有限责任   2,000.0  医药制造销售      1,100.00  55.0  55.00   二   
    责任公司            街2号           -7        公司       0                                    0                  
    5   新疆西帕维药集团有  乌鲁木齐市沈阳  74865734  有限责任   3,000.0  医药制造销售      2,550.00  85.0  85.00   二   
    限公司              街2号           -4        公司       0                                    0                  
    6   武汉当代物业管理有  武汉市洪山区鲁  30009445  有限责任   300.00   物业管理          280.41    93.4  93.47   三   
    限责任公司          磨路369#        -9        公司                                            7                  
    7   武汉人福生物医药研  武汉市洪山区鲁  66954109  有限责任   100.00   生物与医药研发    100.00    100.  100.00  三   
    发有限责任公司      磨路369#        -5        公司                                            00                 
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (二)股权转让日的确定方法
    协议已获股东大会(或股东会)批准通过;已支付购买价款的50%以上;已办理必要的财产交接手续并取得对公司实际控制权时,确定为新增股权的购买日。但如果有关股权转让需要经过国家有关部门批准,则在满足上述条件并且取得国家有关部门的批准文件时才确认。
    
    (三)本公司拥有其半数以上表决权但未纳入合并范围的被投资单位情况
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    被投资单位全称                                        表决权比例(%)                     是否纳入合并范围           
    天津贝龙热力设备有限公司                              85                                  否                         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:子公司广州贝龙环保热力设备股份有限公司将其持有的天津贝龙热力设备有限公司85%股权对外托管,广州贝龙环保热力设备股份有限公司未对其实施控制及重大影响,只保留了分红权及处置权,故采用成本法核算,未纳入合并报表范围。
    
    (四)本公司拥有未达半数以上表决权但纳入合并范围的被投资单位情况
    公司于2001年7月以货币资金与其他股东共同投资设立武汉华山人福药业有限公司,持有49%股权。2001年7月股东余久楠将其持有的武汉华山人福药业有限公司2%股权除分红权、处置权以外的权利全部授权给甲方,公司对武汉华山人福药业有限公司拥有实际控制权,故纳入合并报表范围。
    
    (五)合并范围变更及理由
    1、新增合并范围及理由
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    单位名称                                           持股比例(%)        与公司关系                  备注             
    武汉人福生物医药研发有限责任公司                   100                  三级子公司                  注:             
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:武汉人福生物医药研发有限责任公司系子公司湖北省葛店人福药业有限公司本期新设立的子公司,故新增合并其2008年6月30日资产负债表、2008年3-6月利润表、现金流量表。
    
    八、合并财务报表项目注释
    (一)货币资金
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目             期末数                                              期初数                                          
    原币金额(元)          折算汇  折合人民币金额(元  原币金额(元)      折算汇   折合人民币金额(元 
    率      )                                      率       )                 
    现金             1,338,641.57                    1,338,641.57        1,788,759.74                 1,788,759.74       
    其中:人民币     1,338,641.57            1.00    1,338,641.57        1,788,759.74        1.00     1,788,759.74       
    银行存款         137,707,397.72                  137,707,397.72      131,219,615.02               131,219,615.02     
    其中:人民币     137,378,728.66          1.00    137,378,728.66      131,219,615.02      1.00     131,219,615.02     
    其他货币资金     34,563,579.07                   34,563,579.07       5,408,804.79                 5,408,804.79       
    其中:人民币     34,563,579.07           1.00    34,563,579.07       5,408,804.79        1.00     5,408,804.79       
    合计             173,609,618.36                  173,609,618.36      138,417,179.55               138,417,179.55     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)货币资金期末余额中,用于银行票据保证金的货币资金合计29,854,489.00元;
    (2)除上述事项外,无其他因质押、冻结等原因而对变现有限制或存放在境外有潜在回收风险的款项。
    
    (二)应收票据
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                             期末数(元)                       期初数(元)                     
    银行承兑汇票                                     6,844,430.00                       9,773,427.74                     
    商业承兑汇票                                                                                                         
    合计                                             6,844,430.00                       9,773,427.74                     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:期末无贴现的商业承兑汇票。
    
    (三)应收账款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目               期末数                                          期初数                                            
    金额(元)     比例(%  计提比   坏账准备(元   金额(元)       比例(%  计提比   坏账准备(元) 
    )       例(%)  )                              )       例(%)                 
    单项金额重大       37,071,546.61  14..94   3-10     1,112,146.40   10,371,448.30    5.36     3        311,143.45     
    单项金额不重大但   20,376,224.99  8.21     30-100   7,010,405.94   9,580,180.47     4.95     30-100   6,005,357.40   
    组合信用风险较大                                                                                                     
    其他不重大         190,715,198.7  76.85    3-10     7,287,729.33   173,543,920.84   89.69    3-10     7,913,418.83   
    8                                                                                                 
    合计               248,162,970.3  100.00           15,410,281.67  193,495,549.61   100.00            14,229,919.68  
    8                                                                                                 
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)期末无持本公司5%(含5%)以上股份的股东单位欠款;
    (2)应收账款期末余额中欠款金额最大的前五名债务人合计51,594,795.86 元,占应收账款期末余额的22.17%;
    (3)期末余额中1,000万元(含1,000万元)以上的应收款项确定为单项金额重大,将期末余额中3年以上且单项金额不重大的应收款项确定为单项金额不重大但组合信用风险较大;
    (4)按账龄列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄         期末数                                               期初数                                             
    金额(元)        比例(%)   计提比   坏账准备(元)  金额(元)        比例(%)  计提比   坏账准备(元) 
    例(%)                                               例(%)                   
    1年以内      177,198,244.65    71.40     3        5,315,947.34    111,768,661.76    57.76    3        3,475,782.78   
    1-2年        39,498,433.72     15.92     5        1,974,921.69    49,839,508.00     25.76    5        2,512,478.29   
    2-3年        11,090,067.02     4.47      10       1,109,006.70    22,307,199.38     11.53    10       2,236,301.21   
    3年以上      20,376,224.99     8.21      30-100   7,010,405.94    9,580,180.47      4.95     30-100   6,005,357.40   
    合计         248,162,970.38    100.00            15,410,281.67   193,495,549.61    100.00            14,229,919.68  
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (四)预付款项
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄                                        期末数                               期初数                              
     金额(元)              比例(%)      金额(元)              比例(%)     
    1年以内                                     156,283,666.00          71.81        207,834,450.78          73.55       
    1-2年                                       22,358,585.46           10.27        28,871,825.56           10.22       
    2-3年                                       36,289,672.33           16.67        43,184,329.58           15.28       
    3年以上                                     2,697,439.27            1.25         2,679,415.40            0.95        
    合计                                        217,629,363.06          100.00       282,570,021.32          100.00      
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    注:(1)期末持本公司5%(含5%)以上股份的股东单位武汉当代科技产业集团股份有限公司款项余额为6,466,973.70元,见“财务报表附注十、关联方关系及其交易”;
    (2)预付款项期末余额中,含对武汉理工大学华夏学院预付投资款94,200,000.00元;
    (3)预付账款期末余额中欠款金额最大的前五名债务人合计153,322,973.70元,占应收账款期末余额的70.45%。
    (五)其他应收款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目              期末数                                            期初数                                           
    金额(元)       比例(%  计提比   坏账准备(元)  金额(元)      比例(%)  计提比例  坏账准备(元  
    )       例(%)                                             (%)       )            
    单项金额重大      144,608,635.93   64.93   3        2,351,463.05    191,912,776.24  61.41    0-5       1,772,660.67  
    单项金额不重大但  12,441,827.05    5.59    30--100  5,095,816.15    9,258,675.16    2.96     30-100    4,389,254.63  
    组合信用风险较大                                                                                                     
    其他不重大        65,676,601.95    29.48   3--10    7,118,794.33    111,340,523.75  35.63    3-10      7,639,260.35  
    合计              222,727,064.93   100.00          14,566,073.53   312,511,975.15  100.00             13,801,175.65 
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)期末无持本公司5%(含)以上表决权股份的股东单位欠款;
    (2)其他应收款期末比期初减少30.31%,主要系收回部分往来款所致;
    (3)其他应收款期末余额中欠款金额最大的前五名债务人合计122,692,374.93元,占其他应收款期末余额的58.94%;
    (4)期末余额中1,000万元(含1,000万元)以上的应收款项确定为单项金额重大,将期末余额中3年以上且单项金额不重大的应收款项确定为单项金额不重大但组合信用风险较大;
    (5)按账龄列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄       期末数                                                期初数                                              
    金额(元)        比例(%)   计提比   坏账准备(元)   金额(元)       比例(%)   计提比   坏账准备(元)  
    例(%)                                                例(%)                    
    1年以内    136,476,559.04    61.27     3        4,557,496.29     203,843,889.39   65.23     3.00     3,848,659.58    
    1-2年      49,362,135.86     22.16     5        2,468,106.79     87,553,592.40    28.02     5.00     4,377,679.62    
    2-3年      24,446,542.98     10.98     10       2,444,654.30     11,855,818.20    3.79      10.00    1,185,581.82    
    3年以上    12,441,827.05     5.59      30-100   5,095,816.15     9,258,675.16     2.96      30-100   4,389,254.63    
    合计       222,727,064.93    100.00            14,566,073.53    312,511,975.15   100.00             13,801,175.65   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (六)应收股利
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    被投资单位                                                                 金额(元)                                
    武汉杰士邦卫生用品有限公司                                                 2,000,000.00                              
    合计                                                                       2,000,000.00                              
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (七)存货
    1、存货分类:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                         期末数                                       期初数                                     
    金额(元)               跌价准备(元)      金额(元)              跌价准备(元)     
    原材料及包装物               37,672,097.71            118,349.81          29,953,976.02                              
    在产品                       31,304,273.24                                32,026,937.13                              
    产成品及库存商品             121,280,790.59           1,601,014.66        100,932,289.44          1,373,762.22       
    开发成本及开发产品           276,910,893.88                               275,782,718.76                             
    低值易耗品及其他             1,676,715.77                                 1,548,566.06                               
    合计                         468,844,771.19           1,719,364.47        440,244,487.41          1,373,762.22       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、存货减值准备情况如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                       期初数(元)       本期增加(元)    本期减少                            期末数(元)     
                         转回(元)         转销(元)                        
    原材料及包装物                                118,349.81                                            118,349.81       
    在产品                                                                                                               
    产成品及库存商品           1,373,762.22       227,252.44                                            1,601,014.66     
    开发成本及开发产品                                                                                                   
    低值易耗品及其他                                                                                                     
    合计                       1,373,762.22       345,602.25                                            1,719,364.47     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:本期用于借款抵押的存货原值合计8,493.47万元。
    
    (八)长期股权投资
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                       期末数                                            期初数                                  
    余额(元)                  减值准备(元)        余额(元)            减值准备(元)    
    子公司投资                                                                                                           
    合营企业投资                                                                                                         
    联营企业投资               48,281,287.51                                     45,617,003.83                           
    其他股权投资               267,813,333.00              8,283,333.00          269,713,333.00        8,283,333.00      
    其他长期投资               288,879,023.43                                    130,365,809.55                          
    合计                       604,973,643.94              8,283,333.00          445,696,146.38        8,283,333.00      
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    1、成本法核算的长期股权投资明细情况如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    被投资单位                  投资期   初始投资   持股比   期初数(元   本期增加(   本期减少   分回红利   期末数(元  
    限       成本(万   例(%)  )           元)         (元)     (元)     )          
    元)                                                                            
    武汉市商业银行(现更名为:  长期     515.00     0.274    5,150,000.0                                     5,150,000.0 
    汉口银行股份有限公司)                                   0                                               0           
    四川恒泰环境技术有限责任公  长期     975.00     21.76    9,750,000.0                                     9,750,000.0 
    司                                                       0                                               0           
    武汉理工大学华夏学院        长期     20,580.00           205,800,000                                     205,800,000 
                  .00                                             .00         
    宜昌市商业银行股份有限公司  长期     1,000.00   1.82     10,000,000.                                     10,000,000. 
                  00                                              00          
    北京西妮个人护理用品有限公                               11,700,000.               1,900,000             9,800,000.0 
    司                                                       00                        .00                   0           
    云南制药集团有限公司        长期     828.33     40.00    8,283,333.0                                     8,283,333.0 
                  0                                               0           
    广西师范大学漓江学院        长期     1,858.00            18,580,000.                                     18,580,000. 
                  00                                              00          
    湖北广电阳光慈善文化传媒有  长期     45.00      15.00    450,000.00                                      450,000.00  
    限公司                                                                                                               
    天津贝龙热力设备有限公司             510.00     85.00                                                                
    合计                                                     269,713,333               1,900,000             267,813,333 
                  .00                       .00                   .00         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)公司对四川恒泰环境技术有限责任公司的长期股权投资,只保留了分红权及处置权,未对其实施重大影响,故采用成本法核算,四川恒泰环境技术有限责任公司增资扩股后,公司持股比例由32.50%变更为21.76%;
    (2)公司对武汉理工大学华夏学院投资采用成本法核算;
    (3)公司2006年已将持有的北京西妮个人护理用品有限公司70%股权进行转让,由于未收到购买价款的50%以上,不满足股权转让的确认条件,期末将未收到的股权转让款9,800,000.00元暂挂长期股权投资;
    (4)子公司深圳新鹏生物工程技术有限公司持有云南制药集团有限公司40%股权,由于云南制药集团有限公司系已关停并转的企业,公司未对其实施重大影响,故采用成本法核算,并已全额计提长期股权投资减值准备;
    (5)子公司中国联合生物技术有限公司于2007年与广西师范大学签订协议,出资1,858万元购买广西师范大学在漓江学院的投资额。公司对广西师范大学漓江学院投资采用成本法核算;
    (6)武汉市商业银行现更名为汉口银行股份有限公司,增资扩股后总股本为2,247,845,808.00元,公司持股比例变更为0.274%;
    (7)子公司广州贝龙环保热力设备股份有限公司将其持有的天津贝龙热力设备有限公司85%股权对外托管,广州贝龙环保热力设备股份有限公司未对其实施控制及重大影响,只保留了分红权及处置权,故采用成本法核算,未纳入合并报表范围。
    
    2、权益法核算的长期股权投资明细如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    被投资单位              投资期  初始投资  持股比  期初数(元)  本期增加(   本期减少(元  分回红利(元  期末数(元  
    限      成本(万  例(%                 元)         )            )            )          
    元)      )                                                                         
    天风证券有限责任公司    长期    4,457.58  14.37   35,312,999.7  1,839,745.3  902,408.18                  36,250,336. 
           5             5                                        92          
    成都昌华科技有限责任公  长期    220.00    44.00   1,868,068.61  -233,898.41                              1,634,170.2 
    司                                                                                                       0           
    天津中生OEM销售有限公   长期    10.00     20.00   59,227.94     5,496.88                                 64,724.82   
    司                                                                                                                   
    武汉杰士邦卫生用品有限  长期    200.00    10.00   8,376,707.53  1,955,348.0                              10,332,055. 
    公司                                                            4                                        57          
    合计                                              45,617,003.8  3,566,691.8  902,408.18                  48,281,287. 
           3             6                                        51          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)子公司武汉当代物业发展有限公司持有天风证券有限责任公司(以下简称“天风证券”)6.08%股权,子公司中国联合生物技术有限责任公司持有天风证券8.29%股权,因公司在天风证券董事会中派有代表,故对其具有重大影响,采用权益法核算;
    (2)公司持有武汉杰士邦卫生用品有限公司(以下简称“杰士邦”)10%股权,因公司向杰士邦派出管理人员,故对其具有重大影响,采用权益法核算。
    3、其他长期投资
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                   期末数                                          期初数                                        
    金额(元)                跌价准备(元)          金额(元)               跌价准备(元)         
    当代国际花园项目       288,879,023.43                                  130,365,809.55                                
    合计                   288,879,023.43                                  130,365,809.55                                
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:根据公司2002年年度股东大会决议,武汉当代科技产业集团股份有限公司协议委托本公司经营、开发其所有的当代国际花园项目(原名“曙光嘉园二期项目”)。该项目位置位于武汉市东湖开发区郑桥村,中环线以南,关山二路延长线以西,规划用地总面积332,084平方米(含规划用地),规划建筑面积约365,292.63平方米。该项目产生的收益由本公司享有,并由本公司向武汉当代科技产业集团股份有限公司支付收益补偿金197,200,000.00元。2008年1-6月,当代国际化花园项目收入66,386,081.00元,公司对当代国际花园项目投资收益为20,936,692.02元(已扣除应分摊的收益补偿金)。至本期末止,公司累计支付收益补偿金款项176,419,453.94元。
    
    4、长期股权投资减值准备
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    单位名称                     期初数(元)            本期增加(元)           本期减少(元)          期末数(元)           
    云南制药集团有限公司         8,283,333.00                                                       8,283,333.00         
    合计                         8,283,333.00                                                       8,283,333.00         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (九)投资性房地产
    1、原值
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    期初数(元)             本期增加(元)            本期减少(元)           期末数(元)             
    南湖学生公寓            192,484,636.72                                                        192,484,636.72         
    合计                    192,484,636.72                                                        192,484,636.72         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、累计折旧
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    期初数(元)             本期增加(元)            本期减少(元)           期末数(元)             
    南湖学生公寓            29,445,914.55          2,585,865.30                                   32,031,779.85          
    合计                    29,445,914.55          2,585,865.30                                   32,031,779.85          
    3、净值                 163,038,722.17                                                        160,452,856.87         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:本期用于借款抵押的投资性房地产原值合计19,248.46万元。
    
    (十)固定资产
    1、固定资产原值
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    期初数(元)             本期增加(元)            本期减少(元)           期末数(元)             
    房屋建筑物              297,205,122.42         892,048.12              1,929,060.29           296,168,110.25         
    机器设备                146,274,557.74         7,900,074.26            116,415.00             154,058,217.00         
    运输设备                32,750,768.75          2,053,756.38            625,003.15             34,179,521.98          
    其他设备                38,171,793.12          3,160,603.69            136,554.36             41,195,842.45          
    合计                    514,402,242.03         14,006,482.45           2,807,032.80           525,601,691.68         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、累计折旧
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    期初数(元)             本期增加(元)            本期减少(元)           期末数(元)             
    房屋建筑物              39,972,963.38          4,392,917.47            640,631.93             43,725,248.92          
    机器设备                58,818,864.80          11,172,672.18           34,985.63              69,956,551.35          
    运输设备                12,914,078.92          1,711,373.57            247,290.38             14,378,162.11          
    其他设备                19,622,172.55          1,814,857.66            4,222,282.84           17,214,747.37          
    合计                    131,328,079.65         19,091,820.88           5,145,190.78           145,274,709.75         
    3、固定资产净值         383,074,162.38                                                        380,326,981.93         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    4、固定资产减值准备
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    期初数(元)             本期增加(元)            本期减少(元)           期末数(元)             
    房屋建筑物              27,451.74                                                             27,451.74              
    机器设备                1,849,811.49                                   -78,329.20             1,771,482.29           
    运输设备                                                                                                             
    其他设备                                                                                                             
    合计                    1,877,263.23                                                          1,798,934.03           
    5、固定资产净额         381,196,899.15                                                        378,528,047.90         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)已对因技术陈旧、损坏、长期闲置不用且无转让价值的固定资产计提减值准备1,771,482.29元;
    (2)本期用于借款抵押的固定资产房屋建筑物和机器设备原值合计19,897.36万元。
    
    (十一)在建工程
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                          期初数(元)    本期增加(元   本期转固数(  其他减少(元  期末数(元)  资金来源      
       )             元)          )                                        
    冻干项目改扩建                2,445,000.00                                               2,445,000.00  自筹          
    医药化工原料工业园三期工程    9,690,938.59    511,074.30                                 10,202,012.8  募集及自筹    
                                                  9                           
    6亿只安全套项目               1,411,101.30    594,753.45     255,330.00                  1,750,524.75  募集及自筹    
    新疆维药库房工程              2,734,715.71    308,680.59                                 3,043,396.30  自筹          
    其他项目                      92,365.25       264,612.36     5,777.78      181,522.43    169,677.40    自筹          
    合计                          16,374,120.85   1,679,120.70   261,107.78    181,522.43    17,610,611.3                
                                                  4                           
    减:在建工程减值准备                                                                                                  
    在建工程净额                  16,374,120.85   1,679,120.70   261,107.78    181,522.43    17,610,611.3                
                                                  4                           
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:在建工程本期增加数中,无利息资本化的借款费用。
    (十二)工程物资
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                       期末数(元)                  期初数(元)                
    专用材料                                                                                                             
    专用设备                                                   50,464.29                     50,464.29                   
    预付大型设备款                                             30,000.00                     30,000.00                   
    为生产准备的工具及器具                                                                                               
    合计                                                       80,464.29                     80,464.29                   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (十三)无形资产
    1、原价
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                期初数(元)        本期增加(元)       本期减少(元)      期末数(元)        
    土地使用权                          30,898,392.90                                                30,898,392.90       
    特许经营权                          900,000.00                                                   900,000.00          
    药品经营许可权                      15,383,800.00                                                15,383,800.00       
    专有技术                            38,697,887.57                                                38,697,887.57       
    其他                                53,520.00                                                    53,520.00           
    合计                                85,933,600.47                                                85,933,600.47       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、累计摊销
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                期初数(元)        本期增加(元)       本期减少(元)      期末数(元)        
    土地使用权                          3,623,914.24        326,780.76                               3,950,695.00        
    特许经营权                          307,500.00          22,500.00                                330,000.00          
    药品经营许可权                      4,935,466.43        409,601.94                               5,345,068.37        
    专有技术                            14,751,500.80       857,832.61                               15,609,333.41       
    其他                                8,840.00            4,460.00                                 13,300.00           
    合计                                23,627,221.47       1,621,175.31                             25,248,396.78       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    3、减值准备
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                期初数(元)        本期增加(元)       本期减少(元)      期末数(元)        
    土地使用权                                                                                                           
    特许经营权                                                                                                           
    药品经营许可权                                                                                                       
    专有技术                            2,143,750.03                                                 2,143,750.03        
    其他                                                                                                                 
    合计                                2,143,750.03                                                 2,143,750.03        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    4、账面价值
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                期初数(元)        本期增加(元)       本期减少(元)      期末数(元)        
    土地使用权                          27,274,478.66                                                26,947,697.90       
    特许经营权                          592,500.00                                                   570,000.00          
    药品经营许可权                      10,448,333.57                                                10,038,731.63       
    专有技术                            21,802,636.74                                                20,944,804.13       
    其他                                44,680.00                                                    40,220.00           
    合计                                60,162,628.97                                                58,541,453.66       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)因产业调整,原有的精细化工专有技术已不再具有使用价值和转让价值,已全额计提减值准备;
    (2)本期用于借款抵押的土地使用权原值合计2,193.50万元。
    
    (十四)商誉
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                        期初数(元)       本期增加(元)    本期减少(元)     期末数(元)     
    武汉当代物业发展有限公司                    914,965.58                                              914,965.58       
    武汉康乐药业股份有限公司                    4,241,699.73                                            4,241,699.73     
    武汉华光制药有限责任公司                    132,595.60                                              132,595.60       
    中生爱佳药具发展有限公司                    553,774.71                                              553,774.71       
    上海飞盾贸易有限公司                        802,716.00                                              802,716.00       
    武汉当代物业管理有限责任公司                35,897.83                                               35,897.83        
    合计                                        6,681,649.45                                            6,681,649.45     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (十五)长期待摊费用
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                          原始发生额(元)    期初数(元)       本期增加(元)      本期摊销(元)     期末数(元)       
    中药保护费                    923,912.68        185,930.74                         29,601.96        156,328.78       
    冻干线GMP认证                 320,971.70        209,272.70                         31,914.00        177,358.70       
    医药达标                      292,575.15        224,309.89       209,922.43        37,200.60        397,031.72       
    合计                          1,537,459.53      619,513.33       209,922.43        98,716.56        730,719.20       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (十六)递延所得税资产
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                   期末数(元)                            期初数(元)                          
    资产减值                               2,515,807.10                            1,956,866.74                          
    合计                                   2,515,807.10                            1,956,866.74                          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (十七)短期借款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                   期末数(元)                            期初数(元)                          
    信用借款                                                                       100,000.00                            
    抵押借款                               459,110,000.00                          526,260,000.00                        
    保证借款                               196,030,000.00                          164,930,000.00                        
    质押借款                               40,650,000.00                                                                 
    合计                                   695,790,000.00                          691,290,000.00                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)本期用于抵押借款的抵押物情况见“财务报表附注八、合并财务报表项目注释、(七)、存货、(九)投资性房地产、(十)固定资产、(十三)无形资产”;
    (2)期末抵押借款中,持本公司5%(含5%)以上股份的股东单位武汉当代科技产业集团股份有限公司以其拥有的资产为本公司提供抵押,取得的借款金额为5,500万元;
    (3)期末质押借款中,持本公司5%(含5%)以上股份的股东单位武汉当代科技产业集团股份有限公司以其持有的人福科技股权为本公司提供质押,取得的借款金额为4,065.00万元。
    (4)期末保证借款中,持本公司5%(含5%)以上股份的股东单位武汉当代科技产业集团股份有限公司为本公司提供担保,取得的借款金额为5,000万元,合并报表范围内各公司相互提供担保,取得的借款金额为14,273万元。
    
    (十八)应付票据
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                   期末数(元)                            期初数(元)                          
    银行承兑汇票                           18,052,857.80                           12,231,122.28                         
    商业承兑汇票                           790,000.00                              16,552,463.00                         
    合计                                   18,842,857.80                           28,783,585.28                         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (十九)应付账款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄                           期末数                                     期初数                                     
    金额(元)                比例(%)        金额(元)                 比例(%)       
    1年以内                        97,129,077.89             77.33            77,458,614.28              76.24           
    1-2年                          10,479,586.84             8.34             8,066,449.33               7.94            
    2-3年                          9,699,826.76              7.72             8,485,364.45               8.35            
    3年以上                        8,289,501.50              6.61             7,585,619.32               7.47            
    合计                           125,597,992.99            100.00           101,596,047.38             100.00          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)期末无欠持本公司5%(含5%)以上表决权股份的股东单位款项;
    (2)期末1年以上应付账款合计28,468,915.10元,系对方单位未及时收款暂挂应付账款所致。
    
    (二十)预收款项
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄                                期末数                                   期初数                                  
    金额(元)               比例(%)       金额(元)               比例(%)      
    1年以内                             151,286,027.55           93.41           107,325,640.79           82.82          
    1-2年                               7,535,524.07             4.65            19,282,338.74            14.88          
    2-3年                               1,324,903.14             0.82            1,762,944.94             1.36           
    3年以上                             1,813,541.33             1.12            1,220,639.95             0.94           
    合计                                161,959,996.09           100.00          129,591,564.42           100.00         
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:期末无欠持本公司5%(含5%)以上表决权股份的股东单位款项;
    
    (二十一)应付职工薪酬
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                               期初数(元)         本期增加(元)       本期减少(元)      期末数(元)        
    工资、奖金、津贴和补贴             -64,418.44           39,590,229.69        39,453,336.89       72,474.36           
    职工福利费                         378,997.18           2,241,187.94         2,620,185.12                            
    社会保险费                         169,949.02           7,167,201.16         7,270,724.69        66,425.49           
    住房公积金                         29,638.00            1,735,201.66         1,668,700.66        96,139.00           
    工会经费和职工教育经费             1,062,747.87         622,708.42           457,689.51          1,227,766.78        
    非货币性福利                                                                                                         
    因解除劳动关系给予的补偿                                -4,659.80            -4,659.80                               
    其他                               -1,833.90            3,390.74             3,178.58            -1,621.74           
    其中:以现金结算的股份                                                                                               
    合计                               1,575,079.73         51,355,259.81        51,469,155.65       1,461,183.89        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (二十二)应交税费
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                   期末数(元)                    期初数(元)                  
    所得税                                                 28,063,590.06                   23,896,994.14                 
    增值税                                                 5,468,716.01                    3,892,748.22                  
    营业税                                                 8,805,331.91                    8,981,761.24                  
    城市建设税                                             1,110,014.20                    1,061,349.82                  
    土地增值税                                             -384,166.69                     -381,033.23                   
    印花税                                                 -838.05                         18,853.61                     
    房产税                                                 373,557.97                      98,851.16                     
    个人所得税                                             11,266.34                       2,571,979.37                  
    教育费附加                                             529,184.88                      508,620.51                    
    地方教育发展费                                         985,698.86                      890,068.17                    
    堤防费                                                 242,575.83                      259,418.36                    
    平价基金                                               128,132.16                      27,178.72                     
    土地使用税                                             554,446.92                      260,212.64                    
    其他                                                   673,052.93                      65,438.87                     
    合计                                                   46,560,563.33                   42,152,441.60                 
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:主要税项的计缴标准及税率见“财务报表附注六、主要税项”。
    (二十三)应付股利
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                    期末数(元)                   期初数(元)                  
    国药集团药业股份有限公司                                4,330,800.00                                                 
    宜昌人福药业有限责任公司工会                            54,432.00                      194,154.00                    
    武汉当代科技产业集团股份有限公司                                                       1,823,534.28                  
    武汉仁军投资咨询公司                                                                   605,653.40                    
    杨进                                                                                   209,322.00                    
    孙健                                                    367,500.00                     367,500.00                    
    刘家清                                                                                 174,261.00                    
    武汉奥兴高科技开发有限公司                                                             293,216.00                    
    武汉高科国有控股集团有限公司                            341,740.32                     341,740.32                    
    广州市南越科技发展有限公司                              189,300.00                     189,300.00                    
    湖北中洲垸农场                                          446,849.35                     517,849.35                    
    广州知音实业有限公司                                    126,000.00                     126,000.00                    
    潘瑞军                                                  105,000.00                     105,000.00                    
    杨彬                                                                                   5,250.00                      
    彭蔚华                                                  10,500.00                      10,500.00                     
    高凤                                                    7,200.00                       7,200.00                      
    当代物业职工持股会                                      3,785,100.25                   3,785,100.25                  
    新疆维吾尔医医院                                        456,000.00                                                   
    合计                                                    10,220,421.92                  8,755,580.60                  
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (二十四)其他应付款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄                           期末数                                     期初数                                     
    金额(元)                比例(%)        金额(元)                 比例(%)       
    1年以内                        146,946,014.49            72.42            81,671,330.68              45.20           
    1-2年                          37,088,119.90             18.28            91,773,005.67              50.79           
    2-3年                          13,804,913.70             6.80             5,240,879.43               2.90            
    3年以上                        5,055,623.70              2.49             2,015,068.24               1.11            
    合计                           202,894,671.79            100.00           180,700,284.02             100.00          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:期末无欠持有本公司5%(含5%)以上表决权股份的股东单位款项。
    
    (二十五)一年内到期的非流动负债
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                          期末数(元)                        期初数(元)                       
    信用借款                                                                                                             
    抵押借款                                      11,000,000.00                       11,000,000.00                      
    保证借款                                      15,000,000.00                       14,400,000.00                      
    质押借款                                                                                                             
    合计                                          26,000,000.00                       25,400,000.00                      
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)期末抵押借款中,关联方单位武汉华软软件股份有限公司以其拥有的资产为本公司提供抵押,取得的借款金额为1,100.00万元。期末一年内到期的抵押借款情况列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    提供借款机构                            币种         金额(元)        借款期限                                      
    中国农业银行武汉市江南支行              人民币       11,000,000.00     2005年10月13日-2008年10月13日                 
    合计                                                 11,000,000.00                                                   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (2)期末保证借款中,合并报表范围内各公司相互提供担保,取得的借款金额为1,000.00万元。期末一年内到期的保证借款情况列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    提供借款机构                             币种         金额(元)         借款期限                                    
    交通银行股份有限公司天津通逸支行         人民币       10,000,000.00      2006年3月16日-2008年12月20日                
    合计                                                  10,000,000.00                                                  
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (3)期末保证借款中,非关联方单位提供担保,取得的借款金额为500万元。期末长期保证借款情况列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    提供借款机构                            币种             金额(元)       借款期限                                   
    中国建设银行新疆分行营业部              人民币           5,000,000.00     2006年2月28日-2009年2月27日                
    合计                                                     5,000,000.00                                                
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (二十六)长期借款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    借款类别                                             期末数(元)                    期初数(元)                    
    信用借款                                                                                                             
    抵押借款                                             8,000,000.00                    8,000,000.00                    
    保证借款                                                                             5,000,000.00                    
    质押借款                                                                                                             
    合计                                                 8,000,000.00                    13,000,000.00                   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:本期用于长期借款的抵押物房产原值2,485.11万元,土地原值462.86万元。期末长期抵押借款情况列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    提供借款机构                             币种             金额(元)           借款期限                              
    乌鲁木齐市商业银行营业部                 人民币           8,000,000.00         2007年6月28日-2012年6月27日           
    合计                                                      8,000,000.00                                               
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (二十七)长期应付款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                            期初数(元)          本期增加(元)       本期减少(元)        期末数(元)        
    国债基金                        12,272,728.00                                                    12,272,728.00       
    科技拨款                                                                                                             
    合计                            12,272,728.00                                                    12,272,728.00       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:控股子公司湖北南湖当代学生公寓物业有限公司收到的财政国债资金期末余额为12,272,728.00元,该长期应付款期限15年,根据湖北省财政厅鄂财建函[2005]26号文件《关于下达2005国债转贷资金还本付息的通知》支付本息。
    
    (二十八)专项应付款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                  期初数(元)     本期增加(元)   本期减少(元   期末数(元)  
                                                 )                           
    递延收益宜昌人福药业有限公司收到的政府补助            11,123,333.33    850,000.00                     11,973,333.33 
    递延收益葛店人福药业有限责任公司收到的的政府补助      3,700,000.00     800,000.00                     4,500,000.00  
    递延收益新疆维吾尔药业有限责任公司收到的政府补助                      1,210,000.00     7,385.00       1,202,615.00  
    合计                                                  14,823,333.33    2,860,000.00     7,385.00       17,675,948.33 
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)宜昌人福药业有限公司本期收到政府补助850,000.00万元;
    (2)湖北葛店人福药业有限责任公司本期收到政府补助800,000.00万元;
    (3)新疆维吾尔药业有限责任公司本期收到政府补助1,210,000.00元,并已在本期摊销7,385.00元。
    
    (二十九)递延所得税负债
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                   期末数(元)                            期初数(元)                          
    资产减值                               56,377.42                               49,893.74                             
    合计                                   56,377.42                               49,893.74                             
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三十)股  本
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                     期初数                                期末数                                
    数量                 比例(%)          数量                 比例(%)          
    一、有限售条件股份                                                                                                   
    1、国家持股                                                                                                          
    2、国有法人持股                                                                                                      
    3、其他内资持股                          63,840,510           16.408           63,840,510           16.408           
    其中:                                                                                                               
    境内法人持股                             63,840,510           16.408           63,840,510           16.408           
    境内自然人持股                                                                                                       
    4、外资持股                                                                                                          
    其中:                                                                                                               
    境外法人持股                                                                                                         
    境外自然人持股                                                                                                       
    有限售条件股份合计                       63,840,510           16.408           63,840,510           16.408           
    二、无限售条件流通股份                                                                                               
    1、人民币普通股                          325,245,176          83.592           325,245,176          83.592           
    2、境内上市的外资股                                                                                                  
    3、境外上市的外资股                                                                                                  
    4、其他                                                                                                              
    无限售条件流通股份合计                   325,245,176          83.592           325,245,176          83.592           
    三、股份总数                             389,085,686          100.000          389,085,686          100.000          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (三十一)资本公积
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                      期初数(元)           本期增加(元)         本期减少(元)         期末数(元)          
    股本溢价                  242,348,572.47                                                       242,348,572.47        
    股权投资准备              13,117,024.20                                                        13,117,024.20         
    其他资本公积              18,149.58                                                            18,149.58             
    合计                      255,483,746.25                                                       255,483,746.25        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三十二)盈余公积
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    期初数(元)           本期增加(元)          本期减少(元)         期末数(元)           
    法定盈余公积            49,437,237.77                                                         49,437,237.77          
    任意盈余公积            13,705,782.87                                                         13,705,782.87          
    合计                    63,143,020.64                                                         63,143,020.64          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三十三)未分配利润
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                                                    金额(元)                   
    上年年末余额                                                                            227,864,557.48               
    加:年初未分配利润调整数                                                                                             
    其中:会计政策变更                                                                                                   
    前期差错更正                                                                                                         
    其他                                                                                                                 
    本年年初余额                                                                            227,864,557.48               
    本年增加数                                                                                                           
    其中:本年归属于母公司股东净利润                                                        38,558,312.62                
    其他增加                                                                                                             
    本年减少数                                                                                                           
    其中:本年提取盈余公积数                                                                                             
    本年分配现金股利数                                                                      -5,836,302.45                
    本年分配股票股利数                                                                                                   
    其他减少                                                                                                             
    本年年末余额                                                                            260,586,567.65               
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:根据公司2007年董事会利润分配方案,公司已经与2008年6月12日以2007年末总股本389,085,686元为基数,每10股派发现金0.15元(含税),共计派发现金红利5,836,302.45元。
    (三十四)营业收入和营业成本
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                  营业收入                                          营业成本                                     
    本期累计数(元)         上年同期数(元)         本期累计数(元)       上年同期数(元)      
    主营业务收入          488,723,135.22           323,578,622.19           249,056,118.76         169,342,225.31        
    其他业务收入          3,893,815.01             2,184,536.73             3,544,565.35           1,820,130.08          
    合计                  492,616,950.23           325,763,158.92           252,600,684.11         171,162,355.39        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)营业收入本期比上期增长51.22%,主要系公司加强了企业管理和市场营销,主营业务收入有了较大幅度的提高所致;
    (2)本期公司前五名客户销售的收入合计162,200,761.57 元,占公司营业收入的32.93 %。
    
    1、按行业划分列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目               营业收入                         营业成本                         营业毛利                        
    本期累计数(元   上年同期数(元  本期累计数(元   上年同期数(元  本期累计数(元   上年同期数(元 
    )               )              )               )              )               )             
    医药产品           387,131,578.66   267,576,796.25  176,376,950.44   127,158,892.72  210,754,628.22   140,417,903.53 
    房地产开发         37,764,017.12    25,743,699.73   18,434,569.85    16,376,800.87   19,329,447.27    9,366,898.86   
    其他主营业务收入   63,827,539.44    30,258,126.21   54,244,598.47    25,806,531.72   9,582,940.97     4,451,594.49   
    其他业务收入       3,893,815.01     2,184,536.73    3,544,565.35     1,820,130.08    349,249.66       364,406.65     
    合计               492,616,950.23   325,763,158.92  252,600,684.11   171,162,355.39  240,016,266.12   154,600,803.53 
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、按地区划分列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目             营业收入                          营业成本                         营业毛利                         
    本期累计数(元   上年同期数(元   本期累计数(元   上年同期数(元  本期累计数(元   上年同期数(元  
    )               )               )               )              )               )              
    内销                                                                                                                 
    其中:东北       11,796,314.57    8,256,164.44     4,877,696.91     3,605,313.54    6,918,617.66     4,650,850.90    
    华北             174,993,150.97   103,796,976.62   27,846,757.16    8,942,218.56    147,146,393.81   94,854,758.06   
    华中             157,032,982.60   120,554,253.20   122,306,608.91   91,164,365.05   34,726,373.69    29,389,888.15   
    华东             38,406,202.47    30,997,224.38    18,500,356.57    21,466,698.36   19,905,845.90    9,530,526.02    
    西北             18,519,417.97    14,355,979.41    12,560,189.09    9,534,934.03    5,959,228.88     4,821,045.38    
    西南             33,571,180.03    21,900,178.31    25,279,211.98    19,029,145.14   8,291,968.05     2,871,033.17    
    华南             35,591,807.67    19,868,575.15    22,788,007.06    12,702,091.86   12,803,800.61    7,166,483.29    
    出口             22,705,893.95    6,033,807.40     18,441,856.41    4,717,588.84    4,264,037.54     1,316,218.56    
    合计             492,616,950.23   325,763,158.92   252,600,684.09   171,162,355.39  240,016,266.14   154,600,803.53  
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三十五)营业税金及附加
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                   本期累计数(元)                        上年同期数(元)                      
    营业税                                 1,826,174.78                            1,055,833.52                          
    城市维护建设税                         2,103,495.65                            1,486,503.82                          
    教育费附加                             894,631.62                              629,451.48                            
    堤防费                                 117,951.00                              91,467.48                             
    平抑物价基金                           76,232.52                               34,935.66                             
    地方教育发展金等                       276,876.32                              160,290.35                            
    合计                                   5,295,361.89                            3,458,482.31                          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)主要税项的计缴标准及税率见“财务报表附注六、主要税项”;
    (2)营业税金及附加本期比上期增加53.11%,主要系营业收入增加引起的营业税金及附加相应增加所致。
    
    (三十六)财务费用
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                       本期累计数(元)                     上年同期数(元)                     
    利息支出                                   28,552,369.41                        23,673,003.57                        
    减:利息收入                               1,636,774.42                         1,499,781.22                         
    手续费及其他                               476,753.09                           282,916.66                           
    合计                                       27,392,348.08                        22,456,139.01                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三十七)资产减值损失
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                        本期累计数(元)             上年同期数(元)            
    坏账损失                                                    1,945,259.86                 2,933,952.29                
    存货跌价损失                                                345,602.25                   -169,793.36                 
    可供出售金融资产减值损失                                                                                             
    持有至到期投资减值损失                                                                                               
    长期股权投资减值损失                                                                                                 
    投资性房地产减值损失                                                                                                 
    固定资产减值损失                                                                                                     
    在建工程减值损失                                                                                                     
    无形资产减值损失                                                                                                     
    商誉减值损失                                                                                                         
    其他                                                                                                                 
    合计                                                        2,290,862.11                 2,764,158.93                
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三十八)投资收益
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                            本期累计数(元)                   上年同期数(元)                  
    权益法核算的投资收益                            3,566,691.86                       8,836,893.20                      
    股权投资差额摊销                                902,408.18                         902,408.18                        
    短期投资收益                                                                                                         
    项目处置收益                                                                       154,775.00                        
    成本法核算收益                                                                                                       
    国际花园项目投资收益                            20,936,692.02                      22,499,034.77                     
    其他收益                                                                                                             
    合计                                            23,600,975.70                      30,588,294.79                     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:投资收益不存在汇回的重大限制。
    
    (三十九)营业外收入
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                            本期累计数(元)                   上年同期数(元)                  
    非流动资产处置利得                              6,632.49                           18,039.95                         
    政府补助                                                                                                             
    其他                                            56,298.54                          180,690.53                        
    合计                                            62,931.03                          198,730.48                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (四十)营业外支出
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                            本期累计数(元)                   上年同期数(元)                  
    非流动资产处置损失                              182,926.05                         377,694.82                        
    公益性捐赠支出                                  2,746,747.87                       453,800.00                        
    其他                                            129,306.94                         163,161.03                        
    合计                                            3,058,980.86                       994,655.85                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (四十一)所得税费用   
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                  本期累计数(元)                上年同期数(元)               
    本期所得税费用                                        12,677,778.49                   9,533,224.95                   
    递延所得税费用                                        -383,013.95                     -225,994.14                    
    合计                                                  12,294,764.54                   9,307,230.81                   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (四十二)资产减值准备明细
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                    期初数(元)  本期计提(   本期减少(元)            期末数(元)                            
    元)         转回         转销                                                 
    应收账款坏帐准备        14,229,919.6  1,180,361.9                          15,410,281.66                           
    8             8                                                                              
    其他应收款坏帐准备      13,801,175.6  764,897.88                           14,566,073.53                           
    5                                                                                            
    存货跌价准备            1,373,762.22  345,602.25                           1,719,364.47                            
    可供出售金融资产减值准                                                                                          
    备                                                                                                                   
    持有至到期投资减值准备                                                                                          
    长期股权投资减值准备    8,283,333.00                                      8,283,333.00                            
    投资性房地产减值准备                                                                                            
    固定资产减值准备        1,877,263.23                          78,329.20    1,798,934.03                            
    在建工程减值准备                                                                                                
    无形资产减值准备        2,143,750.03                                       2,143,750.03                            
    商誉减值准备                                                                                                    
    其他                                                                                                            
    合计                    41,709,203.8  2,290,862.1               78,329.20    43,921,736.72                           
    1             1                                                                              
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (四十三)每股收益
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                         本期累计数(元)             上年同期数(元)           
    归属于普通股股东的当期净利润                                 38,558,312.62                26,460,688.01              
    年初发行在外普通股股数                                       389,085,686.00               389,085,686.00             
    报告期因发行新股或债转股等增加的股份数                                                                               
    增加股份下一月份起至报告期期末的月份数                                                                               
    报告期因公积金转赠股本或股票股利分配等增加股份数                                                                     
    增加股份下一月份起至报告期期末的月份数                                                                               
    当期回购普通股股数                                                                                                   
    已回购时间                                                                                                           
    发行在外普通股的加权平均数                                   389,085,686.00               389,085,686.00             
    基本每股收益                                                 0.10                         0.07                       
    调整后的归属于普通股股东的当期净利润                         38,558,312.62                26,460,688.01              
    稀释后的发现在外普通股的加权平均数                           389,085,686.00               389,085,686.00             
    稀释每股收益                                                 0.10                         0.07                       
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)基本每股收益计算过程:按照各期归属于普通股股东的当期净利润,除以发行在外普通股的加权平均数计算得出;
    (2)稀释每股收益计算过程:公司无稀释性潜在普通股,稀释每股收益与基本每股收益相同;
    
    (四十四)现金流量表附注
    1、较大金额的现金流量项目情况
    (1)收到的其他与经营活动有关的现金主要项目如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                                         金额(元)                              
    武汉理工大学华夏学院                                                         56,635,114.25                           
    江西江中制药集团有限责任公司                                                 20,000,000.00                           
    武汉世新环保科技有限责任公司                                                 20,000,000.00                           
    天津贝龙热力设备有限公司                                                     13,000,000.00                           
    天津市乳胶厂                                                                 5,000,000.00                            
    研发补贴款                                                                   4,050,000.00                            
    广西师范大学漓江学院                                                         3,295,772.00                            
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (2)支付的其他与经营活动有关的现金主要项目如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                                      金额(元)                                 
    当代国际花园项目                                                          107,997,039.18                             
    市场推广及促销费                                                          30,811,075.29                              
    广告费                                                                    30,382,560.32                              
    研发费                                                                    12,414,029.00                              
    差旅费                                                                    6,257,156.28                               
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、现金流量表补充资料
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    补充资料                                                                  合并数                                     
                                   本期累计数             上年同期数          
    1、将净利润调节为经营活动现金流量:                                                                                  
    净利润                                                                    48,869,256.43          33,553,714.54       
    加:资产减值准备                                                          2,290,862.11           2,764,158.93        
    固定资产折旧                                                              17,165,038.43          16,612,581.42       
    无形资产摊销                                                              1,621,175.31           1,913,694.67        
    长期待摊费用摊销                                                          98,716.56              120,634.53          
    处置固定资产、无形资产和其他长期资产的损失(减:收益)                    177,089.10             433,735.95          
    固定资产报废损失                                                          104.46                                     
    公允价值变动损失(减:收益)                                                                                         
    财务费用                                                                  27,392,128.08          22,456,139.01       
    投资损失(减:收益)                                                      -23,600,975.70         -30,588,294.79      
    递延所得税资产和递延所得税负债(加:负债,减:资产)                      -552,456.68            -214,809.61         
    存货的减少(减:增加)                                                    -28,254,681.53         -27,669,266.41      
    经营性应收项目的减少(减:增加)                                          90,479,833.00          -56,074,989.26      
    经营性应付项目的增加(减:减少)                                          -56,336,527.80         67,370,435.87       
    其他                                                                                                               
    经营活动产生的现金流量净额                                                79,349,561.77          30,677,734.85       
    2、不涉及现金收支的投资和筹资活动                                                                                    
    债务转为资本                                                                                                         
    一年内到期的可转换公司债券                                                                                           
    融资租入固定资产                                                                                                     
    3、现金及现金等价物净增加情况:                                                                                      
    现金的期末余额                                                            173,609,618.36         168,336,115.45      
    减:现金的期初余额                                                        138,417,179.55         332,345,889.27      
    加:现金等价物的期末余额                                                                                             
    减:现金等价物的期初余额                                                                                             
    现金及现金等价物净增加额                                                  35,192,438.81          -164,009,773.82     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    九、母公司财务报表项目注释
    (一)应收账款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目               期末数                                          期初数                                            
    金额(元)      比例(  计提比   坏账准备(元   金额(元)      比例(%   计提比   坏账准备(元) 
    %)     例(%)  )                             )        例(%)                 
    单项金额重大                                                                                                         
    单项金额不重大但   730,470.05      100.00  100.00   730,470.05     730,470.05      100.00    30-100   674,900.66     
    组合信用风险较大                                                                                                     
    其他不重大                                                                                                           
    合计               730,470.05      100.00           730,470.05     730,470.05      100.00             674,900.66     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)期末无持本公司5%(含5%)以上股份的股东单位欠款;
    (2)应收账款期末余额中欠款金额最大的前五名债务人合计665,594.04元,占应收账款期末余额的91.12%,现已全额计提坏账准备;
    (3)期末余额中1,000万元(含1,000万元)以上的应收款项确定为单项金额重大,将期末余额中3年以上且单项金额不重大的应收款项确定为单项金额不重大但组合信用风险较大;
    (4)按账龄列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄         期末数                                               期初数                                             
    金额(元)       比例(%)   计提比例  坏账准备(元)  金额(元)       比例(%)   计提比   坏账准备(元) 
    (%)                                                  例(%)                   
    1年以内                                 3                                                    3                       
    1-2年                                   5                                                    5                       
    2-3年                                   10                                                   10                      
    3年以上      730,470.05       100.00    30-100    730,470.05      730,470.05       100.00    30-100   674,900.66     
    合计         730,470.05       100.00              730,470.05      730,470.05       100.00             674,900.66     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (二)其他应收款
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目               期末数                                           期初数                                           
    金额(元)      比例(%  计提比例(  坏账准备(元  金额(元)       比例(%  计提比例  坏账准备(元  
    )       %)         )                             )       (%)       )            
    单项金额重大       160,852,508.98  74.03   0-5        1,178,150.00  176,185,881.39   67.45   0-3       599,347.62    
    单项金额不重大但   1,593,269.80    0.73    30-100     1,230,731.56  2,037,913.03     0.78    30-100    1,364,124.53  
    组合信用风险较大                                                                                                     
    其他不重大         54,845,222.32   25.24   3-10       1,636,834.35  82,981,176.62    31.77   3-10      2,209,762.35  
    合计               217,291,001.10  100.00             4,045,715.91  261,204,971.04   100.00            4,173,234.50  
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)期末无持本公司5%(含)以上表决权股份的股东单位欠款;
    (2)其他应收款期末余额中欠款金额最大的前五名债务人合计101,692,374.93元,占其他应收款期末余额的46.80%;
    (3)期末余额中1,000万元(含1,000万元)以上的应收款项确定为单项金额重大,将期末余额中3年以上且单项金额不重大的应收款项确定为单项金额不重大但组合信用风险较大;
    (4)按账龄列示如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    账龄        期末数                                               期初数                                              
    金额(元)         比例(%)  计提比   坏账准备(元)  金额(元)        比例(%)   计提比   坏账准备(元) 
    例(%)                                                例(%)                   
    1年以内     179,047,022.46     82.40    3        914,448.91      239,843,761.90    91.82     3        1,774,945.16   
    1-2年       35,290,708.84      16.24    5        1,764,535.44    17,963,296.11     6.88      5        898,164.81     
    2-3年       1,360,000.00       0.63     10       136,000.00      1,360,000.00      0.52      10       136,000.00     
    3年以上     1,593,269.80       0.73     30-100   1,230,731.56    2,037,913.03      0.78      30-100   1,364,124.53   
    合计        217,291,001.10     100.00            4,045,715.91    261,204,971.04    100.00             4,173,234.50   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    (三)长期股权投资
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                期末数                                   期初数                                  
    余额(元)             减值准备(元)    余额(元)             减值准备(元)   
    子公司投资                          714,846,237.10                           714,846,237.10                          
    合营企业投资                                                                                                         
    联营企业投资                        10,332,055.57                            8,376,707.53                            
    其他股权投资                        230,950,000.00                           232,850,000.00                          
    其他长期投资                        288,879,023.43                           130,365,809.55                          
    合计                                1,245,007,316.10                         1,086,438,754.18                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    1、成本法核算的长期股权投资明细情况如下:
    (1)子公司投资
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    被投资单位               投资期  初始投资  持股比  期初数(元)  本期增加(   本期减少(   期末数(元)  分回红利(  
    限      成本(万  例(%                 元)         元)                       元)        
    元)      )                                                                        
    武汉人福药业有限责任公   长期    4,782.14  95.642  47,821,361.0                            47,821,361.0              
    司                                         722     0                                       0                         
    广州贝龙环保热力设备股   长期    2,030.00  58.00   20,300,000.0                            20,300,000.0              
    份有限公司                                         0                                       0                         
    武汉当代物业发展有限公   长期    5,100.00  85.00   50,999,999.6                            50,999,999.6              
    司                                                 8                                       8                         
    武汉人福医用光学电子有   长期    350.00    70.00   3,500,000.00                            3,500,000.00              
    限公司                                                                                                               
    武汉人福益民医药有限公   长期    373.33    70.00   3,733,300.00                            3,733,300.00              
    司                                                                                                                   
    湖北省葛店人福药业有限   长期    6,290.25  94.65   62,902,516.9                            62,902,516.9              
    公司                                               5                                       5                         
    新疆维吾尔自治区维吾尔   长期    1,099.94  55.00   10,999,445.9                            10,999,445.9  1,304,000.0 
    药业有限责任公司                                   4                                       4             0           
    武汉康乐药业股份有限公   长期    3,335.46  99.00   33,354,608.4                            33,354,608.4              
    司                                                 0                                       0                         
    武汉华山人福药业有限公   长期    980.00    49.00   9,800,000.00                            9,800,000.00              
    司                                                                                                                   
    宜昌人福药业有限责任公   长期    12,766.6  70.00   127,666,032.                            127,666,032.  15,157,800. 
    司                               0                 22                                      22            00          
    中国联合生物技术有限责   长期    8,741.54  66.00   87,415,377.4                            87,415,377.4              
    任公司                                             6                                       6                         
    湖北南湖当代学生公寓物   长期    12,500.0  92.31   124,999,955.                            124,999,955.              
    业有限公司                       0                 13                                      13                        
    新疆西帕维药集团有限公   长期    2,550.00  85.00   25,500,000.0                            25,500,000.0              
    司                                                 0                                       0                         
    天津中生乳胶有限公司     长期    5,814.11  90.00   58,141,106.4                            58,141,106.4              
            4                                       4                         
    武汉天润健康产品有限公   长期    489.15    90.00   4,891,454.86                            4,891,454.86              
    司                                                                                                                   
    深圳新鹏生物工程技术有   长期    4,282.11  52.00   42,821,079.0                            42,821,079.0              
    限公司                                             2                                       2                         
    合计                                               714,846,237.                            714,846,237.  16,461,800. 
            10                                      10            00          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (2)其他股权投资
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    被投资单位               投资期  初始投资  持股比  期初数(元   本期增加(元  本期减少(   期末数(元)  分回红利(  
    限      成本(万  例(%   )           )            元)                       元)        
    元)      )                                                                        
    武汉市商业银行(现更名   长期    515.00    0.274   5,150,000.0                             5,150,000.00              
    为汉口银行股份有限公司                             0                                                                 
    )                                                                                                                   
    四川恒泰环境技术有限责   长期    975.00    21.76   9,750,000.0                             9,750,000.00              
    任公司                                             0                                                                 
    武汉理工大学华夏学院     长期    20,580.0  0.00    205,800,000                             205,800,000.              
    0                 .00                                     00                        
    北京西妮个人护理用品有                             11,700,000.                1,900,000.0  9,800,000.00              
    限公司                                             00                         0                                      
    湖北广电阳光慈善文化传   长期    45.00     15.00   450,000.00                              450,000.00                
    媒有限公司                                                                                                           
    合计                                               232,850,000                1,900,000.0  230,950,000.              
            .00                        0            00                        
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)公司对四川恒泰环境技术有限责任公司的长期股权投资,只保留了分红权及处置权,未对其实施重大影响,故采用成本法核算, 四川恒泰环境技术有限责任公司增资扩股后,公司持股比例由32.50%变更为21.76%;
    (2)公司对武汉理工大学华夏学院投资采用成本法核算;
    (3)公司2006年已将持有的北京西妮个人护理用品有限公司70%股权进行转让,由于未收到购买价款的50%以上,不满足股权转让的确认条件,期末将未收到的股权转让款9,800,000.00元暂挂长期股权投资。
    (4)武汉市商业银行现更名为汉口银行股份有限公司,增资扩股后总股本为2,247,845,808.00元,公司持股比例变更为0.274%;
    
    2、权益法核算的长期股权投资明细如下:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    被投资单位                    投资   初始投资  持股   期初数(元   本期增加(   本期减少(   分回红利(  期末数(元  
    期限   成本(万  比例   )           元)         元)         元)        )          
    元)      (%)                                                                 
    武汉杰士邦卫生用品有限公司    长期   200.00    10.00  8,376,707.5  1,955,348.0                           10,332,055. 
               3            4                                     57          
    合计                                                  8,376,707.5  1,955,348.0                           10,332,055. 
               3            4                                     57          
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:公司持有武汉杰士邦卫生用品有限公司(以下简称“杰士邦”)10%股权,因公司向杰士邦派出管理人员,故对其具有重大影响,采用权益法核算。
    3、其他长期投资
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                   期末数                                          期初数                                        
    金额(元)                跌价准备(元)          金额(元)               跌价准备(元)         
    当代国际花园项目       288,879,023.43                                  -130,365,809.55                               
    合计                   288,879,023.43                                  130,365,809.55                                
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:根据公司2002年年度股东大会决议,武汉当代科技产业集团股份有限公司协议委托本公司经营、开发其所有的当代国际花园项目(原名“曙光嘉园二期项目”)。该项目位置位于武汉市东湖开发区郑桥村,中环线以南,关山二路延长线以西,规划用地总面积332,084平方米(含规划用地),规划建筑面积约365,292.63平方米。该项目产生的收益由本公司享有,并由本公司向武汉当代科技产业集团股份有限公司支付收益补偿金197,200,000.00元。2008年1-6月,当代国际化花园项目收入66,386,081.00元,公司对当代国际花园项目投资收益为20,936,692.02元(已扣除应分摊的收益补偿金)。至本期末止,公司累计支付收益补偿金款项176,419,453.94元。
    (四)投资收益
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                            本期累计数(元)                   上年同期数(元)                  
    权益增减                                        1,955,348.04                       1,259,054.49                      
    股权投资差额摊销                                                                                                     
    短期投资收益                                                                                                         
    项目处置收益                                                                                                         
    成本法核算收益                                  16,461,800.00                                                        
    国际花园项目投资收益                            20,936,692.02                      22,499,034.77                     
    其他收益                                                                                                             
    合计                                            39,353,840.06                      23,758,089.26                     
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:投资收益不存在汇回的重大限制。
    
    十、关联方关系及其交易
    (一)关联方认定标准
    根据《企业会计准则第36号——关联方披露》,一方控制、共同控制另一方或对另一方施加重大影响,以及两方或两方以上同受一方控制、共同控制或重大影响的,构成关联方。
    根据《上市公司信息披露管理办法》(中国证券监督管理委员会令第40号),将特定情形的关联法人和关联自然人也认定为关联方。
    
    (二)关联方关系
    1、母公司及最终控制方情况
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    公司名称                注册地              组织机构代码   业务性质         与本公  注册资本(  对本公司   对本公司  
                                     司关系  万元)      持股比例   表决权比  
                                                         (%)      例(%)   
    武汉当代科技产业集团股  武汉市洪山区鲁磨路  17806826-4     高科技投资、投   母公司  10,000.00   16.408     16.408    
    份有限公司              369号                              资管理                                                    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    2、子公司情况说明
    子公司情况说明见“财务报表附注七、企业合并及合并财务报表”。
    
    3、合营及联营企业情况说明
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    公司名称               注册地            组织机构   业务性质                         注册资本  本公司合   本公司合计 
    代码                                        (万元)  计持股比   表决权比例 
                                                        例(%)    (%)      
    一、合营企业                                                                                                         
    -                                                                                                                    
    二、联营企业                                                                                                         
    武汉杰士邦卫生用品有   武汉市洪山区鲁磨  72577818-  计生用品制造和销售               2,000.00  10.00      10.00      
    限公司                 路369#            6                                                                           
    成都昌华科技有限责任   成都高新区桂溪工  79215237-  药物的研究、开发及技术转让       500.00    44.00      44.00      
    公司                   业园              8                                                                           
    天津中生OEM销售有限公  天津空港物流加工  78334518-  乳胶制品的经营及技术开发、转让   50.00     20.00      20.00      
    司                     区西十四道223号   6          、咨询、服务                                                     
    天风证券经纪有限责任   湖北省武汉市东湖  71189444-  证券的代理买卖;代理还本付息和   18,100.0  14.37      14.37      
    公司                   新技术开发区关东  2          分红派息;证券代保管、鉴证;代   0                               
    园路2号高科大厦4             理登记开户;证券的自营买卖;证                                   
    楼                           券承销和上市推荐                                                 
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    4、其他关联方
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    公司名称                                   组织机构代码                       与本公司的关系                         
    广西师范大学漓江学院                       75976008-0                         联合办学                               
    武汉理工大学华夏学院                       75703829-7                         联合办学                               
    武汉华软软件股份有限公司                   70717350-3                         武汉理工大学华夏学院之子公司           
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    (三)关联方交易
    1、销售货物
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    关联方名称                   本期累计数                                  上年同期数                                  
    金额(元)          占销货的比  定价政策    金额(元)         占销货的比例  定价政策   
          例(%)                                    (%)                    
    武汉杰士邦卫生用品有限公司                                   市场价      12,625,580.90      32.45         市场价     
    天津中生OEM销售有限公司      325,968.00          0.07        市场价      502,312.00         1.29          市场价     
    合计                         325,968.00          0.07                    13,127,892.90      33.74                    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    2、采购货物
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    关联方名称                    本期累计数                                 上年同期数                                  
    金额(元)      占采购的比   定价政策      金额(元)        占采购的比   定价政策     
       例(%)                                      例(%)                   
    武汉杰士邦卫生用品有限公司    17,342,262.33   6.87         市场价                                                    
    合计                          17,342,262.33   6.87                                                                   
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    3、其他关联方交易
    根据公司2002年年度股东大会决议,武汉当代科技产业集团股份有限公司协议委托本公司经营、开发其所有的当代国际花园项目(原名“曙光嘉园二期项目”)。该项目位置位于武汉市东湖开发区郑桥村,中环线以南,关山二路延长线以西,规划用地总面积332,084平方米(含规划用地),规划建筑面积约365,292.63平方米。该项目产生的收益由本公司享有,并由本公司向武汉当代科技产业集团股份有限公司支付收益补偿金197,200,000.00元。2008年1-6月,当代国际化花园项目收入66,386,081.00元,公司对当代国际花园项目投资收益为20,936,692.02元(已扣除应分摊的收益补偿金)。至本期末止,公司累计支付收益补偿金款项176,419,453.94元。
    4、关联方担保事项
    (1)公司为关联方担保事项
    公司为广西师范大学漓江学院借款提供的担保金额为9,000.00万元。
    (2)关联方为公司提供担保抵押事项
    A、期末抵押借款中,持本公司5%(含5%)以上股份的股东单位武汉当代科技产业集团股份有限公司以其拥有的资产为本公司提供抵押,取得的借款金额为5,500.00万元。
    B、期末抵押借款中,持本公司5%(含5%)以上股份的股东单位武汉当代科技产业集团股份有限公司以其持有的人福科技股权为本公司提供抵押,取得的借款金额为4,065.00万元。
    C、期末保证借款中,持本公司5%(含5%)以上股份的股东单位武汉当代科技产业集团股份有限公司为本公司提供担保,取得的借款金额为5,000.00万元。
    D、期末抵押借款中,关联方单位武汉华软软件股份有限公司以其拥有的资产为本公司提供抵押,取得的借款金额为1,100.00万元。
    
    5、未结算项目款项
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    关联方名称                                      期末数                              期初数                           
         金额(元)           占该项目的比   金额(元)           占该项目的  
                              例(%)                               比例(%)     
    应收账款:                                      1,858,767.72         0.80           2,948,368.24         1.52        
    武汉杰士邦卫生用品有限公司                      564,042.22           0.24           1,979,610.74         1.02        
    天津中生OEM销售有限公司                         1,294,725.50         0.56           968,757.50           0.50        
                                                                              
    预付账款:                                      100,666,973.70       46.26          105,745,980.20       37.43       
    武汉当代科技产业集团股份有限公司                6,466,973.70         2.97           11,545,980.20        4.09        
    武汉理工大学华夏学院                            94,200,000.00        43.29          94,200,000.00        33.34       
                                                                              
    其他应收款:                                    112,142,374.93       53.87          151,073,261.18       48.34       
    武汉理工大学华夏学院                            58,197,190.80        27.96          113,832,305.05       36.43       
    广西师范大学漓江学院                            31,340,184.13        15.06          34,635,956.13        11.08       
    武汉华软软件股份有限公司                        22,605,000.00        10.85          2,605,000.00         0.83        
                                                                              
    应付账款:                                      17,653,273.64        14.06          18,250,817.48        17.96       
    武汉杰士邦卫生用品有限公司                      17,653,273.64        14.06          18,250,817.48        17.96       
                                                                              
    其他应付款:                                    5,000,489.48         2.46           1,266,342.43         0.70        
    天津中生OEM销售有限公司                         100,000.00           0.05           100,000.00           0.05        
    成都昌华科技有限责任公司                        100,000.00           0.05           12,570.45            0.01        
    天风证券有限责任公司                            1,800,489.48         0.88           1,150,839.48         0.64        
    武汉杰士邦卫生用品有限公司                      3.000,000.00         1.48                                            
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    十一、或有事项
    截止报告日止,公司无重大需披露的或有事项。
    
    十二、承诺事项
    截止报告日止,公司无重大需披露的承诺事项。
    
    十三、资产负债表日后事项
    截止报告日,公司无重大需披露的资产负债表日后事项。
    
    十四、其他重要事项
    截止报告日,公司无重大需披露的其他重要事项。
     补充资料:
    
    武汉人福高科技产业股份有限公司
    财务报表补充资料
    (2008年中期)
    金额单位:人民币元
    
    一、净资产收益率及每股收益
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                       净资产收益率(%)                      每股收益(人民币元)                 
    全面摊薄           加权平均          基本每股收益       稀释每股收益      
    归属于公司普通股股东的净利润               3.98               4.04              0.10               0.10              
    扣除非经常性损益后归属于公司普通股股东的   4.16               4.22              0.10               0.10              
    净利润                                                                                                               
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    
    非经常性损益情况:
    
    
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    项目                                                                                      金额(元)                 
    一、归属于公司普通股股东的净利润                                                          38,558,312.62              
    二、减:非经常性损益项目                                                                  -2,996,049.83              
    其中:非流动资产处置损益                                                                  -169,080.95                
    越权审批或无正式批准文件的税收返还、减免                                                                             
    计入当期损益的政府补助                                                                                               
    计入当期损益的对非金融企业收取的资金占用费                                                                           
    合并成本小于合并时应享有被合并单位可辨认净资产公允价值产生的损益                                                     
    非货币性资产交换损益                                                                                                 
    委托投资损益                                                                                                         
    因不可抗力因素,如遭受自然灾害而计提的各项资产减值准备                                                               
    债务重组损益                                                                                                         
    企业重组费用,如安置职工的支出、整合费用等                                                                           
    交易价格显失公允的交易产生的超过公允价值部分的损益                                                                   
    同一控制下企业合并产生的子公司期初至合并日的当期净损益                                                               
    与公司主营业务无关的预计负债产生的损益                                                                               
    除上述各项之外的其他营业外收支净额                                                        -2,826,968.88              
    其他非经常性损益项目                                                                                                 
    三、加:非经常性损益的所得税影响数                                                        -629,592.62                
    归属于少数股东非经常性损益的影响数                                                        -596,412.71                
    四、扣除非经常性损益后归属于公司普通股股东的净利润                                        40,328,357.12              
    ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
    注:(1)本公司净资产收益率及每股收益依照中国证监会会计字[2007]9号关于《公开发行证券公司信息披露编报规则第9号——净资产收益率和每股收益的计算及披露》(2007年修订)所载的计算公式计算;
    (2)本公司对非经常性损益项目的确认依照中国证监会会计字[2007]9号关于《公开发行证券的公司信息披露规范问答第1号——非经常性损益》(2007年修订)的规定执行。
    
    
    
    
    武汉人福高科技产业股份有限公司
    
    2008年7月28日
     第八章   备查文件
    
    一、载有法定代表人签名的二〇〇八年半年度报告文本;
    二、载有单位负责人、主管会计工作的负责人、会计机构负责人签名并盖章的财务报告文本;
    三、报告期内在中国证监会指定报刊上公开披露过的所有文件的正本及公告的原稿;
    四、公司全体董事、监事、高级管理人员对公司二〇〇八年半年度报告的书面确认意见;
    五、《公司章程》;
    六、其他有关资料。        
    
    
    
    
    董事长:王学海
    武汉人福高科技产业股份有限公司董事会
    二〇〇八年七月二十八日
    
    
    
    武汉人福高科技产业股份有限公司董事
    对公司二〇〇八年半年度报告的书面确认意见
                                           
    
    
    根据《证券法》第68条规定、中国证监会《公开发行证券的公司信息披露内容与格式准则第3号<半年度报告的内容与格式>》(2007年修订)和《上海证券交易所股票上市规则》等有关规定的相关要求,公司董事在全面了解和审阅公司二〇〇八年半年度报告后,发表以下书面意见:
    1、公司严格按照股份公司财务制度规范运作,公司二〇〇八年半年度报告全面、公允的反映了公司本报告期的财务状况和经营成果;
    2、公司二〇〇八年半年度报告全文及其摘要经公司第六届董事会第六次会议审议一致通过。公司全体董事出席了本次董事会会议。
    3、本公司全体董事保证公司二〇〇八年半年度报告所披露的信息真实、准确、完整,承诺本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
    
    
    全体董事签名:
    
    
    王学海    李  杰    艾路明    张小东    邓霞飞
    
    朱建斌    谢获宝    莫洪宪    杨祥良    
    
    
    
    武汉人福高科技产业股份有限公司董事会
    
    二〇〇八年七月二十八日
    
    
    武汉人福高科技产业股份有限公司监事
    对公司二〇〇八年半年度报告的书面确认意见
                                           
    
    
    根据《证券法》第68条规定、中国证监会《公开发行证券的公司信息披露内容与格式准则第3号<半年度报告的内容与格式>》(2007年修订)和《上海证券交易所股票上市规则》等有关规定的相关要求,公司全体监事在全面了解和审阅公司二〇〇八年半年度报告后,发表以下书面意见:
    1、公司严格按照股份公司财务制度规范运作,公司二〇〇八年半年度报告全面、公允的反映了公司本报告期的财务状况和经营成果;
    2、公司二〇〇八年半年度报告全文及其摘要经公司第六届董事会第六次会议、第六届监事会第四次会议审议一致通过。全体董事、监事、高级管理人员均出席了相关会议。
    3、本公司全体监事保证公司二〇〇八年半年度报告及其摘要所披露的信息真实、准确、完整,承诺本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
    全体监事签名:
    杜越新    齐谋甲    明华    杜燕云    李光静
    武汉人福高科技产业股份有限公司监事会
    2008年七月二十八日
    武汉人福高科技产业股份有限公司高级管理人员
    对公司二〇〇八年半年度报告的书面确认意见
    根据《证券法》第68条规定、中国证监会《公开发行证券的公司信息披露内容与格式准则第3号<半年度报告的内容与格式>》(2007年修订)和《上海证券交易所股票上市规则》等有关规定的相关要求,公司全体高级管理人员在全面了解和审阅公司二〇〇八年半年度报告后,发表以下书面意见:
    1、公司严格按照股份公司财务制度规范运作,公司二〇〇八年半年度报告全面、公允的反映了公司本报告期的财务状况和经营成果;
    2、本公司全体高级管理人员保证公司二〇〇八年半年度报告所披露的信息真实、准确、完整,承诺本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
    全体高级管理人员签名:
    李 杰  邓霞飞    吴亚君    杜文涛
    徐华斌  李名学    刘  毅
    武汉人福高科技产业股份有限公司
    2008年七月二十八日